<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/181123</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Developmental Biology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epigenomic and 3D genome architecture in na&#x00EF;ve and primed human embryonic stem cell states</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Battle</surname><given-names>Stephanie L.</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jayavelu</surname><given-names>Naresh Doni</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="author-notes" rid="n1">6</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Azad</surname><given-names>Robert N.</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="author-notes" rid="n1">6</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hesson</surname><given-names>Jennifer</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ahmed</surname><given-names>Faria N.</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zoller</surname><given-names>Joseph A.</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Mathieu</surname><given-names>Julie</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5588-4531</contrib-id>
<name><surname>Ruohola-Baker</surname><given-names>Hannele</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ware</surname><given-names>Carol B.</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2997-9457</contrib-id>
<name><surname>David Hawkins</surname><given-names>R.</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Division of Medical Genetics, Department of Medicine, Department of Genome Sciences, University of Washington School of Medicine</institution>, Seattle, WA <country>USA</country></aff>
<aff id="a2"><label>2</label><institution>Institute for Stem Cell and Regenerative Medicine, University of Washington School of Medicine</institution>, Seattle, WA <country>USA</country></aff>
<aff id="a3"><label>3</label><institution>Turku Centre for Biotechnology</institution>, Turku, <country>Finland</country></aff>
<aff id="a4"><label>4</label><institution>Department of Comparative Medicine, University of Washington School of Medicine</institution>, Seattle, WA, <country>USA</country></aff>
<aff id="a5"><label>5</label><institution>Department of Biochemistry, University of Washington School of Medicine</institution>, Seattle, WA, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: <email>rdhawk@uw.edu</email></corresp>
<fn id="n1" fn-type="equal"><label>6</label><p>These authors contributed equally to this work.</p></fn>
</author-notes>
<pub-date pub-type="epub"><year>2017</year></pub-date>
<elocation-id>181123</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>25</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>8</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2017, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="181123.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>ABSTRACT</title>
<p>During mammalian embryogenesis changes in morphology and gene expression are concurrent with epigenomic reprogramming. Using human embryonic stem cells representing the pre-implantation blastocyst (na&#x00EF;ve) and post-implantation epiblast (primed), our data demonstrate that a substantial portion of known human enhancers are pre-marked by H3K4me1 in na&#x00EF;ve cells, providing an enhanced open chromatin state in na&#x00EF;ve pluripotency. The na&#x00EF;ve enhancer repertoire occupies nine percent of the genome, three times that of primed cells, and can exist in broad chromatin domains over fifty kilobases. Enhancer chromatin states are largely poised. Seventy-seven percent of na&#x00EF;ve enhancers are decommissioned in a stepwise manner as cells become primed. While primed topological associated domains are unaltered upon differentiation, na&#x00EF;ve domains expand across primed boundaries, impacting three dimensional genome architecture. Differential topological associated domain edges coincide with na&#x00EF;ve H3K4me1 enrichment. Our results suggest that na&#x00EF;ve-derived cells have a chromatin landscape reflective of early embryogenesis.</p>
</abstract>
<counts>
<page-count count="38"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>INTRODUCTION</title>
<p>Dynamic changes in the epigenome are concerted with morphological and gene expression changes during early embryogenesis. Soon after fertilization DNA methylation is actively removed from the paternal genome, passively lost from the maternal genome and regained in the post-implantation epiblast(<xref ref-type="bibr" rid="c26">Guo et al., 2014</xref>). In addition to resetting the DNA methylome, the early embryonic epigenome maintains an open chromatin structure as repressive heterochromatin is gained later over the course of development, lineage commitment and differentiation(<xref ref-type="bibr" rid="c2">Ahmed et al., 2010</xref>; <xref ref-type="bibr" rid="c43">Liu et al., 2004</xref>; <xref ref-type="bibr" rid="c58">Sarmento et al., 2004</xref>). These changes in histone modifications correlate with the hypothesis that a more open chromatin structure is a key aspect of pluripotency and allows embryonic cells to respond to a broad array of developmental signaling cues(<xref ref-type="bibr" rid="c28">Hawkins et al., 2010</xref>; <xref ref-type="bibr" rid="c47">Meshorer et al., 2006</xref>).</p>
<p>Pre- and post-implantation pluripotent ESCs provide a system to model epigenomic reprogramming during early embryogenesis and to study changes in pluripotency. Mouse ESCs (mESCs) are currently the primary model for studying mammalian pre-implantation embryos and deemed na&#x00EF;ve(<xref ref-type="bibr" rid="c62">Silva and Smith, 2008</xref>), while mouse epiblast stem cells (EpiSCs) model the post-implantation embryo and exist in the primed state of pluripotency(<xref ref-type="bibr" rid="c9">Brons et al., 2007</xref>; <xref ref-type="bibr" rid="c65">Tesar et al., 2007</xref>). Due to a number of similarities between mouse EpiSCs and human ESCs (hESCs), it is now accepted that hESCs exist in the primed state(<xref ref-type="bibr" rid="c49">Nichols and Smith, 2009</xref>). However, several groups described the first set of na&#x00EF;ve hESCs, where primed hESCs or human iPSCs were induced, or reset, to the na&#x00EF;ve state(<xref ref-type="bibr" rid="c10">Chan et al., 2013</xref>; <xref ref-type="bibr" rid="c21">Gafni et al., 2013</xref>; <xref ref-type="bibr" rid="c27">Hanna et al., 2010</xref>; <xref ref-type="bibr" rid="c64">Takashima et al., 2014</xref>; <xref ref-type="bibr" rid="c67">Theunissen et al., 2014</xref>; <xref ref-type="bibr" rid="c69">Valamehr et al., 2014</xref>; <xref ref-type="bibr" rid="c72">Ware et al., 2014</xref>). Additionally, new hESC lines were derived, each under a different na&#x00EF;ve growth condition(<xref ref-type="bibr" rid="c21">Gafni et al., 2013</xref>; <xref ref-type="bibr" rid="c25">Guo et al., 2016</xref>; <xref ref-type="bibr" rid="c67">Theunissen et al., 2014</xref>; <xref ref-type="bibr" rid="c72">Ware et al., 2014</xref>) (for review see(<xref ref-type="bibr" rid="c71">Ware, 2016</xref>)). Similar to mouse, na&#x00EF;ve hESCs exhibit DNA hypomethylation and two active X chromosomes(<xref ref-type="bibr" rid="c21">Gafni et al., 2013</xref>; <xref ref-type="bibr" rid="c66">Theunissen et al., 2016</xref>; <xref ref-type="bibr" rid="c72">Ware et al., 2014</xref>), hallmarks of the pre-implantation state.</p>
<p>Given the differences between early human and mouse embryogenesis(<xref ref-type="bibr" rid="c7">Blakeley et al., 2015</xref>; <xref ref-type="bibr" rid="c56">Rossant, 2015</xref>), na&#x00EF;ve-derived hESC lines provide an opportunity to study changes that are reflective of early human development and pluripotency. To better our understanding of epigenomic reprogramming as hESCs transition from the pre-implantation to post-implantation state, we present data from whole transcriptome RNA-seq, ChIP-seq for five histone modifications, and topological associated domains (TADs) from in situ DNaseI Hi-C for the na&#x00EF;ve-derived Elf1 line(<xref ref-type="bibr" rid="c72">Ware et al., 2014</xref>) grown in 2i &#x002B; Lif &#x002B; IGF1 &#x002B; FGF (2iLIF). We include data from cells transitioning from the na&#x00EF;ve state (Activin &#x002B; FGF noted as AF) and compared our results to data from primed H1 hESC(<xref ref-type="bibr" rid="c18">Dixon et al., 2012</xref>; <xref ref-type="bibr" rid="c28">Hawkins et al., 2010</xref>). Extensive chromatin remodeling occurs at promoters and enhancer elements as cells transition from na&#x00EF;ve to primed. Our analysis reveals that na&#x00EF;ve hESCs have a more open chromatin structure due to large expansions of H3K4me1 and H3K27ac in the genome. Seventy-seven percent of na&#x00EF;ve enhancers are decommissioned in the primed state. TADs are largely stable between pluripotent states, but our data reveal limited na&#x00EF;ve specific shifts in TAD boundaries. Overall, these data provide an extensive view of the epigenome and 3D genome for hESC states and a model of epigenomic reprogramming during early human embryogenesis.</p>
</sec>
<sec id="s2">
<title>RESULTS</title>
<sec id="s2a">
<title>Gene Expression in Na&#x00EF;ve hESCs</title>
<p>Na&#x00EF;ve and primed hESCs are expected to have distinct expression profiles, and na&#x00EF;ve cells should reflect aspects of human blastocyst gene expression. We performed strand-specific, whole transcriptome RNA-seq in replicate on Elf1 na&#x00EF;ve (2iLIF), Elf1 transitioning (AF) and H1 primed (mTeSR) cells of equal cell numbers (Supplementary Figure 1a-c; see methods for growth conditions). We identified differentially expressed genes (DEGs) in a pairwise manner (<xref rid="fig1" ref-type="fig">Fig. 1a, b</xref>). The largest number of DEGs was observed between na&#x00EF;ve and primed hESCs (<xref rid="fig1" ref-type="fig">Fig. 1b</xref> and Supplementary Table 1), signifying just how distinct these cellular states are. Highlighted are several genes known to be upregulated in the human pre-implantation epiblast(<xref ref-type="bibr" rid="c7">Blakeley et al., 2015</xref>; <xref ref-type="bibr" rid="c77">Yan et al., 2013</xref>) and other genes of interest, indicating that the characteristics we observe for 2iLIF na&#x00EF;ve cells are reflective of pre-implantation development.</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Differential Gene Expression</title>
<p>(a-b) Volcano plot of differentially expressed genes (DEGs) in na&#x00EF;ve versus transitioning (a) and na&#x00EF;ve versus primed (b) pairwise comparison. Genes in magenta have P-adj &#x003C; 0.01 and fold change &#x2265; 2 while genes in green have P-adj &#x003C; 0.01 and fold change &#x2265; 4. (c-d) Heatmap showing significantly overrepresented GO terms and KEGG pathways based on DEGs in na&#x00EF;ve versus transitioning (c) and na&#x00EF;ve versus primed (d) pairwise comparison. (e) Hierarchical clustering of transposable elements gene expression separates na&#x00EF;ve from primed hESCs. (f) Percentage of genes upregulated in pairwise comparison of na&#x00EF;ve or primed hESCs that are also found to be upregulated in human embryo developmental stages.</p></caption>
<graphic xlink:href="181123_fig1.tif"/>
</fig>
<p>We determined gene ontology (GO) categories and KEGG pathways for na&#x00EF;ve DEGs, which were significantly enriched for embryo development and pluripotency signaling pathways along with other pathways important during pre-implantation development (<xref rid="fig1" ref-type="fig">Fig. 1c,d</xref>). In particular, genes in the TGF-beta pathway were found to be upregulated in na&#x00EF;ve cells, including <italic>LEFTY1</italic>, <italic>SMAD3</italic> and <italic>NODAL</italic> (Supplementary Fig. 1d). The TGF-beta pathway was shown to be important for maintenance of <italic>NANOG</italic> in the human epiblast, whereas inhibition of this pathway has insignificant effects on mouse embryos(<xref ref-type="bibr" rid="c7">Blakeley et al., 2015</xref>). PI3K-AKT signaling pathway was also enriched, and is known to promote ESC self-renewal through inhibition of ERK signaling pathway(Supplementary Fig. 1e) (<xref ref-type="bibr" rid="c11">Chen et al., 2012</xref>). The WNT signaling pathway was enriched for na&#x00EF;ve upregulated genes including <italic>WNT8A</italic>, <italic>WNT5B</italic> and <italic>TCF7</italic> (Supplementary Fig. 1f)(<xref ref-type="bibr" rid="c63">Sperber et al., 2015</xref>). A number of terms associated with embryonic development and morphogenesis were enriched for na&#x00EF;ve upregulated genes. This may foreshadow what happens to the cells of the blastocyst as they prepare to become the embryonic disk of the epiblast.</p>
<p>We identified cell type-specific genes in the different hESC stages by applying a cutoff of a RPKM value greater than or equal to two in one cell type and less than one in the other two cell types (Supplemental Fig 2). Using this cutoff we determined 429 na&#x00EF;ve-specific genes, 229 transition-specific genes and 333 primed-specific genes. Compared to the primed states, na&#x00EF;ve-specific genes were enriched for GO terms associated with morphogenesis and pattern specification (Supplemental Fig 2). This is due, in part, to the many <italic>HOX</italic> genes that are uniquely expressed in na&#x00EF;ve hESCs and not in transitioning or primed cells. Primed cells were enriched for terms associated with extracellular communication and protein/histone demethylation.</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Overview of Chromatin States</title>
<p>Global view of chromatin structure for na&#x00EF;ve (navy), transitioning (cyan) and primed (orange) hESCs. These colors are used throughout all figures. (a) UCSC Genome Browser images of <italic>TBX3</italic> and CDX2 gene loci showing enrichment of H3K4mel (RPKM range l-20), H3K27ac (RPKM range 1-20), and H3K27me3 (RPKM range 1-30) in na&#x00EF;ve, transitioning and primed cells. (b) The number of ChIP-seq peaks called by MACS with FDR cutoff &#x2264; 0.05. (c) The percent of genome covered by each histone modification (number of bases divided by effective genorne size: 2.7e&#x002B;09). (d) Promoters were classified based on the criteria pictured - also see main text. (e) Violin plots showing the distribution of RPKM values of nearest neighboring genes of active, poised and bivalent promoter peaks in each cell type. P-values for pairwise comparisons are computed using two tailed t-tests with pooled SD. P-values are adjusted with Benjamini-Hochberg method. &#x002A;&#x002A;&#x002A; P-value &#x003C; 0.001;. (f) Sankey plot of primed bivalent gene promoters and their origins from the na&#x00EF;ve state. (g) Significance of GO Terms from bivalently mark ed gene promoters.</p></caption>
<graphic xlink:href="181123_fig2.tif"/>
</fig>
<p>A recent report showed that the transposable element (TE) transcriptome can be used as a state-specific signature in hESCs(<xref ref-type="bibr" rid="c66">Theunissen et al., 2016</xref>). Na&#x00EF;ve and primed hESCs segregate when clustered on the top 1,000 highly expressed TEs (<xref rid="fig1" ref-type="fig">Fig. 1e</xref>). Lastly, we compared upregulated genes to human embryo RNA-seq data from Yan et al.(<xref ref-type="bibr" rid="c77">Yan et al., 2013</xref>). We find that a similar percentage of upregulated genes from na&#x00EF;ve and primed are expressed in pre-zygotic genome activation stages, while na&#x00EF;ve hESCs share more upregulated genes with the post-ZGA embryo than primed (<xref rid="fig1" ref-type="fig">Fig. 1f</xref>). This strengthens reports that na&#x00EF;ve cells are a good representative model of the pre-implantation stage of human development(<xref ref-type="bibr" rid="c63">Sperber et al., 2015</xref>; <xref ref-type="bibr" rid="c72">Ware et al., 2014</xref>).</p>
</sec>
<sec id="s2b">
<title>Global Chromatin Features of Na&#x00EF;ve hESCs</title>
<p>To assess global chromatin dynamics between the cellular states, we performed ChIP-seq on five histone modifications from na&#x00EF;ve and transitioning cells (Supplementary Table 2,3), and used data previously generated in H1 hESCs for the primed state(<xref ref-type="bibr" rid="c28">Hawkins et al., 2010</xref>). These modifications include: H3K4me3 for Pol II-bound promoters(<xref ref-type="bibr" rid="c4">Barski et al., 2007</xref>; <xref ref-type="bibr" rid="c24">Guenther et al., 2007</xref>; <xref ref-type="bibr" rid="c32">Heintzman et al., 2007</xref>), H3K4me1 for enhancers(<xref ref-type="bibr" rid="c31">Heintzman et al., 2009</xref>; <xref ref-type="bibr" rid="c32">Heintzman et al., 2007</xref>), H3K27ac for active regions(<xref ref-type="bibr" rid="c29">Hawkins et al., 2011</xref>; <xref ref-type="bibr" rid="c31">Heintzman et al., 2009</xref>), H3K27me3 for Polycomb repressed regions(<xref ref-type="bibr" rid="c5">Bernstein et al., 2006</xref>; <xref ref-type="bibr" rid="c8">Boyer et al., 2006</xref>), and H3K9me3 for heterochromatin(<xref ref-type="bibr" rid="c3">Bannister et al., 2001</xref>; <xref ref-type="bibr" rid="c4">Barski et al., 2007</xref>). All five modifications along with ChIP inputs were sequenced in duplicates for both Elf1 na&#x00EF;ve and Elf1 transitioning cells for a total of &#x003E; 270 million and &#x003E;213 million sequencing reads respectively (Supplementary Table 2,3).</p>
<p>We inspected genes with known expression differences during early embryogenesis through the blastocyst/epiblast stage to ensure our chromatin maps reflect changes during differentiation from na&#x00EF;ve to primed. <italic>TBX3</italic> was shown to be expressed in na&#x00EF;ve ESCs and human epiblasts(<xref ref-type="bibr" rid="c7">Blakeley et al., 2015</xref>). The <italic>TBX3</italic> locus exhibits high levels of H3K4me1 and H3K27ac in na&#x00EF;ve hESCs, a reduction of H3K27ac in the transitioning state, followed by a reduction of H3K4me1 and a gain of H3K27me3 in primed hESCs (<xref rid="fig2" ref-type="fig">Fig. 2a</xref>). <italic>KLF2</italic>, which was shown not to be expressed in human na&#x00EF;ve cells(<xref ref-type="bibr" rid="c7">Blakeley et al., 2015</xref>), lacks the H3K27ac modification in all three hESC stages (Supplementary Figure 3a). <italic>CDX2</italic> has active histone modifications in na&#x00EF;ve hESCs but transitions to lost acetylation and gained H3K27me3 in primed hESCs (<xref rid="fig2" ref-type="fig">Fig. 2b</xref>). CDX2 has been shown to be expressed after blastocyst formation in human embryos and overlaps OCT4 expression in preimplantation embryos(<xref ref-type="bibr" rid="c48">Niakan and Eggan, 2013</xref>). Expansion of H3K27me3 domains are also shown at the <italic>HOXA</italic> locus as hESC move from na&#x00EF;ve to primed (Supplementary Figure 3b). Next, we asked whether these trends observed at specific loci held true genome-wide.</p>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Na&#x00EF;ve Enhancer Repertoire</title>
<p>(a) Venn diagram of na&#x00EF;ve (navy) enhancers overlapped with transitioning (cyan) and primed (orange) enhancers. (b) Heatmap of H3K4me1 normalized ChIP-seq signal centered at na&#x00EF;ve-specific enhancers in a 5kb window. (c) Percent of hESC H3K4me1 genomic space (&#x0025; bases or enhancer-verse) occupied by ENCODE DHSs from 177 cell types (d) Number of ENCODE DHS from 177 cell types overlapping with na&#x00EF;ve and primed H3K4me1 enhancers (e) Distribution of active (H3K4me1 &#x002B; H3K27ac) and poised (H3K4me1 only or H3K4me1 &#x002B; H3K27me3) enhancer states in each cell type.</p></caption>
<graphic xlink:href="181123_fig3.tif"/>
</fig>
<p>Previous studies, including our own work, in na&#x00EF;ve hESCs observed a reduction of H3K27me3 in na&#x00EF;ve derived and reset hESCs(<xref ref-type="bibr" rid="c10">Chan et al., 2013</xref>; <xref ref-type="bibr" rid="c21">Gafni et al., 2013</xref>; <xref ref-type="bibr" rid="c63">Sperber et al., 2015</xref>; <xref ref-type="bibr" rid="c67">Theunissen et al., 2014</xref>; <xref ref-type="bibr" rid="c72">Ware et al., 2014</xref>), consistent with what was shown in na&#x00EF;ve mESCs(<xref ref-type="bibr" rid="c46">Marks et al., 2012</xref>). Comparisons across cell types reveal a genome-wide depletion of repressive histone modifications in na&#x00EF;ve cells (<xref rid="fig2" ref-type="fig">Fig. 2b,c</xref>). H3K27me3 repressed regions are more abundant and broader in primed than in na&#x00EF;ve cells, covering &#x223C;1.4&#x0025; of the genome in primed cells compared to 0.5&#x0025; in na&#x00EF;ve (<xref rid="fig2" ref-type="fig">Fig. 2b</xref>, Supplemental Figure 3c), which we previously showed is linked to metabolic differences between the cell states(<xref ref-type="bibr" rid="c63">Sperber et al., 2015</xref>). H3K9me3 heterochromatin regions, which are sparse in primed cells(<xref ref-type="bibr" rid="c28">Hawkins et al., 2010</xref>), are further depleted in transitioning and na&#x00EF;ve cells (<xref rid="fig2" ref-type="fig">Fig. 2b,c</xref> and Supplementary Figure 3d and Supplementary Table 4,5). There is a notable abundance of H3K4me1 regions in na&#x00EF;ve hESCs (<xref rid="fig2" ref-type="fig">Fig. 2b</xref> and Supplementary Table 4). Over 9&#x0025; of the na&#x00EF;ve genome is marked by H3K4me1, three times more than primed cells and 1.7 times more than transitioning cells (<xref rid="fig2" ref-type="fig">Fig. 2c</xref> and Supplementary Table 5). Monomethylation is present in larger domains, reaching sizes of over 30kb in transitioning cells and over 50kb in na&#x00EF;ve cells (Supplemental Fig. 3e). Acetylation is also more enriched in na&#x00EF;ve cells with 3x more peaks than primed, and broad H3K27ac domains reaching over 50kb (<xref rid="fig2" ref-type="fig">Fig. 2b,c</xref>, Supplemental Figure 3f and Supplementary Table 4,5). The trends for H3K27 modifications also hold true on the X chromosome (Supplementary Fig. 3h-j), where both are active in na&#x00EF;ve cells(<xref ref-type="bibr" rid="c72">Ware et al., 2014</xref>). We found H3K4me3 to be the most stable mark though cell-specific peaks exist (<xref rid="fig2" ref-type="fig">Fig. 2b,c</xref> and Supplementary Fig. 3g).</p>
</sec>
<sec id="s2c">
<title>Promoter Transitions from Na&#x00EF;ve to Primed State</title>
<p>We investigated how DEGs were reflected through promoter chromatin states using &#x003E;19,000 GENCODE defined autosomal protein coding genes. Over 12,000 promoters are marked with H3K4me3 (Supplementary Figure 4a). We subdivided promoters into six categories: (1) active - H3K4me3 and H3K27ac; (2) poised - H3K4me3 only; (3) bivalent - H3K4me3 and H3K27me3; H3K27ac - H3K27ac only; (5) H3K27me3 - H3K27me3 only; and (6) unmarked - lacking all three modifications (<xref rid="fig2" ref-type="fig">Fig. 2d</xref> and Supplementary Figure 4b). Although the largest percentages of gene promoters remain static as either active or unmarked across all three stages, many promoters change chromatin state (Supplementary Figure 4c), which exemplifies the dynamic nature of the epigenome. To illustrate that chromatin patterns coincide with general trends of expression, we plotted the RPKM values of genes with active, poised and bivalent promoters. As expected, genes with active promoters had overall higher expression levels than genes with promoters in the other two categories (<xref rid="fig2" ref-type="fig">Fig. 2e</xref>).</p>
<fig id="fig4" position="float" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Na&#x00EF;ve Enhancers are Decommissioned but Active in Other Cell Types</title>
<p>(a) UCSC Genome Browser image illustrating loss of H3K27ac, followed by loss of H3K4me1 at the <italic>H19</italic> the H19 locus as cells move from na&#x00EF;ve (navy), to transitioning (cyan), to primed (orange); RPKM range 1-20 for each track. This region also contains a broad enhancer domain in na&#x00EF;ve hESCs. Enhancer peak calls are represented as bars above the H3K4mei track. (b) Percent of shared na&#x00EF;ve enhancers genornic space that is preserved in the follow hESC states. &#x00A9; Heatmaps of H3K4mei and H3K27ac normalized ChIP-seq signal at broad enhancer regions (&#x2265;5kb). (d) Histograms of average H3K4mei and H3K27ac normalized ChIP-seq signal at all broad enhancers or broad H3K27ac domains. (e) Violin plots showing the distribution of RPKM values of nearest neighboring genes of all broad enhancers (H3K4me 1 &#x2265;5kb) and active broad enhancers (H3K4mel &#x2265;5kb overlapping H3K27ac Z5kb) in each cell type. P-values for pairwise comparisons are computed using two tailed t-tests with pooled SD. P-values are adjusted with Benjarnini-Hochberg method. &#x002A; P-value &#x003C; 0.05; &#x002A;&#x002A; P-value &#x003C;0.01; &#x002A;&#x002A;&#x002A; P-value &#x003C;0.001.</p></caption>
<graphic xlink:href="181123_fig4.tif"/>
</fig>
<p>Mouse ESCs grown in serum have a greater than three-fold increase in bivalent promoters relative to cells of the mouse ICM (<xref ref-type="bibr" rid="c44">Liu et al., 2016</xref>). Observing a similar increase in bivalent gene promoters from na&#x00EF;ve to primed cells (1,097 vs 2,674), we determined from which epigenetic states the primed bivalent promoters arose. Roughly 60&#x0025; of primed bivalent promoters are bivalent in transitioning cells, and of those, their promoter states are split between active (42&#x0025;), bivalent (32&#x0025;) and poised (20&#x0025;) in na&#x00EF;ve hESCs (<xref rid="fig2" ref-type="fig">Fig. 2f</xref>). Of the &#x223C;7&#x0025; of na&#x00EF;ve active gene promoters that become bivalent in transitioning cells, these genes were enriched for GO terms such as morphogenesis and WNT signaling, and includes genes such as <italic>HOXA1</italic>, <italic>HOXA4</italic>, <italic>HOXD8</italic> and <italic>ZEB1</italic>. Na&#x00EF;ve bivalent genes fall into categories involving GO terms for synaptic transmission, ion transport and neuron differentiation (<xref rid="fig2" ref-type="fig">Fig. 2g</xref>). Thus, it appears that the neural lineage is the first lineage to be bivalently marked in na&#x00EF;ve cells and suggests that na&#x00EF;ve hESCs may be an excellent model for further investigation of the establishment of Polycomb repressive regions in the early epigenome.</p>
</sec>
<sec id="s2d">
<title>Enhancers in the Na&#x00EF;ve Embryonic State</title>
<p>Enhancer elements are <italic>cis</italic>-acting regulatory sequences that control gene expression via interaction with transcription factors and promoters. Enhancer chromatin modifications are highly dynamic and cell type-specific(<xref ref-type="bibr" rid="c28">Hawkins et al., 2010</xref>). Here, we defined enhancers as H3K4me1 peaks lacking overlap with H3K4me3 (Supplementary Table 6). Investigation of the enhancer landscape across hESC states revealed that na&#x00EF;ve cells harbor the most cell type-specific enhancers (&#x003E;47k; <xref rid="fig3" ref-type="fig">Fig. 3a,b</xref>), while transitioning and primed cells had roughly the same number of unique enhancers at &#x223C;17k and &#x223C;14k respectively (Supplementary Figure 5a-d). Sixty-four percent of transitioning enhancers and 55&#x0025; of primed enhancers are marked in the na&#x00EF;ve state (Supplementary Figure 5a,b). We asked if the expansion of na&#x00EF;ve H3K4me1 was random or occurred at known regulatory elements. Using DNase I Hypersensitive Sites (DHS) data from 177 ENCODE cells(<xref ref-type="bibr" rid="c12">Consortium, 2012</xref>), including H1, we found 25-30&#x0025; of the H3K4me1-marked genome (enhancer-verse) to be hypersensitive in each cell type (<xref rid="fig3" ref-type="fig">Fig. 3c</xref>). Of the 177 cell and tissue types, fetal tissues had the largest collection of DHS overlapping na&#x00EF;ve enhancers (<xref rid="fig3" ref-type="fig">Fig. 3d</xref> and Supplementary Table 7). Additionally, over 92&#x0025; of the enhancer base pairs covered by na&#x00EF;ve H3K4me1 peaks are utilized as enhancers in 127 Roadmap Epigenome Project cell types, as indicated by H3K4me1 (Supplementary Figure 5e-f). Single cell RNA-seq data from early human embryogenesis(<xref ref-type="bibr" rid="c77">Yan et al., 2013</xref>) indicates that 92&#x0025; of annotated transcription factors(<xref ref-type="bibr" rid="c78">Zhang et al., 2015</xref>) are expressed by the late blastocyst stage (Supplemental Figure 5g). Their expression provides a plausible means for aiding the localization of H3K4me1 to known enhancers.</p>
<fig id="fig5" position="float" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Na&#x00EF;ve Enhancers from Various Na&#x00EF;ve Culture Conditions</title>
<p>ChIP-Seq of na&#x00EF;ve cells grown in different culture conditions including na&#x00EF;ve Elf1 na&#x00EF;ve (navy), Elf1 4iLIF (purple), Elf1 AF (transitioning - cyan), primed H1 mTeSR (orange), na&#x00EF;ve H1 4iLIF (red), na&#x00EF;ve LIS1 4iLIF (green). (a) H3K4me1 enrichment in different growth conditions at <italic>DNMT3L</italic> (top panel) and <italic>SOX2</italic> loci (bottom panel) (b) Average ChIP-Seq signal at na&#x00EF;ve-specific enhancers (top panel) and primed-specific enhancers (bottom panel). (c) Heatmap of H3K4me1 ChIP-Seq signal at naive specific enhancers. (d) PCA of top 500 10kb bins of H3K4me1 with largest variance.</p></caption>
<graphic xlink:href="181123_fig5.tif"/>
</fig>
<p>Enhancer elements can exist in distinct chromatin states that indicate whether they are active or poised (<xref rid="fig3" ref-type="fig">Fig. 3e</xref>)(<xref ref-type="bibr" rid="c14">Creyghton et al., 2010</xref>; <xref ref-type="bibr" rid="c29">Hawkins et al., 2011</xref>; <xref ref-type="bibr" rid="c53">Rada-Iglesias et al., 2011</xref>). We characterized differences in the classes of enhancers in each hESC state. We defined active enhancers as regions having H3K4me1 and H3K27ac and poised enhancers as regions with either H3K4me1-only or H3K4me1 and H3K27me3. In all three stages of pluripotency, the majority of enhancers are in the H3K4me1-only poised state (67&#x0025;, 84&#x0025;, and 73&#x0025; in na&#x00EF;ve, transitioning and primed cells respectively; <xref rid="fig3" ref-type="fig">Fig. 3e</xref>). There is an increase of H3K27me3 containing poised enhancers moving from na&#x00EF;ve to primed (1&#x0025; to 4&#x0025;; <xref rid="fig3" ref-type="fig">Fig. 3e</xref>), which correlates with the increase of H3K27me3.</p>
<p>Our comparative analysis of enhancers indicates that both active and H3K4me1-only poised enhancers are largely decommissioned as na&#x00EF;ve hESCs transition to the primed state (<xref rid="fig4" ref-type="fig">Fig. 4a</xref>). When assessing overlapping H3K4me1 peaks across hESCs, we see that the chromatin-marked genomic space of na&#x00EF;ve enhancers is greatly reduced in primed cells (<xref rid="fig4" ref-type="fig">Fig. 4a,b</xref>). This process happens in a stepwise manner, as is evidenced by the loss of acetylation as cells exit the na&#x00EF;ve state followed by the gradual loss H3K4me1 (<xref rid="fig4" ref-type="fig">Fig. 4a,b</xref>). This introduces a different view of development compared to previous studies that showed poised enhancers gain acetylation following differentiation and were often enriched near genes that became activated later in development(<xref ref-type="bibr" rid="c14">Creyghton et al., 2010</xref>; <xref ref-type="bibr" rid="c29">Hawkins et al., 2011</xref>; <xref ref-type="bibr" rid="c53">Rada-Iglesias et al., 2011</xref>). By using na&#x00EF;ve hESCs as a model, we can infer that not only is H3K4me1 likely maintaining open chromatin to aid in the pluripotency phenotype, but that a substantial fraction of enhancers in the human genome are pre-marked early during embryogenesis and subsequently decommissioned during priming.</p>
</sec>
<sec id="s2e">
<title>Broad Enhancer Domains in the Na&#x00EF;ve Epigenome</title>
<p>Super(<xref ref-type="bibr" rid="c74">Whyte et al., 2013</xref>) and stretch(<xref ref-type="bibr" rid="c51">Parker et al., 2013</xref>) enhancers, which are largely based on H3K27ac, were originally identified in primed ESCs. These regions were shown to upregulate nearby genes and were stronger than conventional enhancers. We asked to what degree these regions were present in our na&#x00EF;ve hESCs. To identify both broad H3K4me1 and H3K27ac domains, we identified regions &#x2265;5kb in all cell types (<xref rid="fig4" ref-type="fig">Fig. 4c</xref>). The H3K4me1 broad enhancers are almost 20 times more abundant in the na&#x00EF;ve epigenome compared to the primed hESC stage (7,412 in na&#x00EF;ve hESCs compared to 371 in primed) with an average size of 8.1kb compared to 6.1kb in primed (Supplementary Figure 5h,i). The number of broad enhancers steadily declines as hESCs transition from na&#x00EF;ve to primed. We observed the same trend with H3K27ac broad domains (2,330 in na&#x00EF;ve compared to 803 in primed), although the number of broad H3K27ac domains in na&#x00EF;ve cells is three times less than the number of H3K4me1 broad enhancers (Supplementary Figure 5h). As a control, we looked for broad H3K4me3 peaks, which were limited across the different hESC stages (Supplementary Figure 5h).</p>
<p>Next, we determined if H3K4me1 broad enhancers and H3K27ac broad domains occupy the same genomic space. The average number of bases contained within the overlap of broad H3K4me1 and H3K27ac domains is over 70&#x0025; of the average length of each domain (Supplementary Figure 5i). Over 78&#x0025; of broad H3K27ac domains in na&#x00EF;ve cells are found within H3K4me1 broad enhancers (Supplementary Figure 5j). In the na&#x00EF;ve and primed states 87&#x0025; and 71&#x0025; of H3K4me1 broad enhancers, respectively, contained some overlap with H3K27ac, indicating that they are active enhancers (<xref rid="fig4" ref-type="fig">Fig. 4d</xref> and Supplementary Figure 5j). The average ChIP-seq signal for H3K4me1 is high at H3K27ac broad domains in all cells except primed hESCs (<xref rid="fig4" ref-type="fig">Fig 4d</xref>). The active state of broad enhancers is supported by the distribution of expression values of nearest neighboring genes (NNGs; <xref rid="fig4" ref-type="fig">Fig. 4e</xref>). Only in the primed state are there more broad H3K27ac domains than H3K4me1 domains and the difference in the expression distribution of NNGs at broad enhancers versus active broad enhancers in primed cells was the only comparison not found to be significant (<xref rid="fig4" ref-type="fig">Fig. 4e</xref>). This may explain why H3K27ac was originally associated with &#x201C;super/stretch&#x201D; enhancers. The frequent occurrence of H3K4me1 and H3K27ac broad domains, where broad H3K27ac domains lie within broad enhancers, provides an additional means of giving the genome its &#x201C;open structure&#x201D; in na&#x00EF;ve pluripotency.</p>
</sec>
<sec id="s2f">
<title>Na&#x00EF;ve hESCs Enhancers in Different Growth Conditions</title>
<p>To determine if the expansion of H3K4me1 in the na&#x00EF;ve epigenome was indicative of the na&#x00EF;ve state and independent of a single growth condition or cell line, we grew three lines in 4i (2i &#x002B; p38 kinase inhibitor &#x002B; JNK inhibitor) &#x002B; Lif &#x002B; IGF1 &#x002B; FGF (referred to as 4iLIF): Elf1, H1 reset to na&#x00EF;ve and the na&#x00EF;ve derived LIS1 line(<xref ref-type="bibr" rid="c21">Gafni et al., 2013</xref>), which grew slightly better in 4iLIF compared to the original growth conditions and compared their transcriptomes for similarity (Supplemental Figure 6a,b). In order to determine the effect of growth conditions and genetic background on the enhancer landscape, we compared the enhancer profiles from H3K4me1 ChIP-seq data across cell types and conditions. Overall, all na&#x00EF;ve cells have a similar enhancer profile (<xref rid="fig5" ref-type="fig">Fig. 5a</xref>). Cells grown in 4iLIF exhibit a stronger enhancer signal at Elf1 2iLIF na&#x00EF;ve-specific enhancers (<xref rid="fig5" ref-type="fig">Fig. 5b,c</xref>), and less enrichment at primed- and transitioning-specific enhancers (<xref rid="fig5" ref-type="fig">Fig. 5b</xref> and Supplementary Figure 6c). PCA of H3K4me1 signal reveals that all lines grown in 4iLIF are largely indistinguishable, and most similar to 2iLIF (<xref rid="fig5" ref-type="fig">Fig. 5d</xref>). Transitioning cells (Elf1 AF) have na&#x00EF;ve-like enhancer profiles as mentioned above, transitioning cells have lost na&#x00EF;ve H3K27ac but have not yet lost H3K4me1 to primed levels. Our analysis suggests that na&#x00EF;ve 2iLIF enhancers do not vary greatly in 4iLIF na&#x00EF;ve conditions, although 2iLIF na&#x00EF;ve hESCs have some distinct H3K4me1 features. The expansion of H3K4me1 regardless of cell line or growth condition confirms this as a new signature of the na&#x00EF;ve hESC state. The acquired expansion upon resetting primed H1 cells to na&#x00EF;ve may suggest that this epigenetic feature is necessary for maintenance in the na&#x00EF;ve state. Further experiments will be needed to confirm this hypothesis.</p>
<fig id="fig6" position="float" fig-type="figure">
<label>Figure 6.</label>
<caption><title>3D Genome Architecture in Na&#x00EF;ve hESCs</title>
<p>(a) Hi-C contact heatmap of chromosome 3 in na&#x00EF;ve cells at 500kb resolution. (b) Boxplots of the insulation scores along chr7 at both TAD centers and boundaries for both na&#x00EF;ve and primed cells. P-values are computed using individual Wilcoxon signed-rank tests. (c) Global size distributions of TADs within na&#x00EF;ve and primed cells (left panel) and size differences of overlapping TADs (40kb bin resolution) in na&#x00EF;ve and primed cells (right panel). (d) Differential heatmap of na&#x00EF;ve minus primed Hi-C bin signal centered at na&#x00EF;ve-specific boundary regions. Negative (red) values indicate a stronger bin signal in primed cells relative to na&#x00EF;ve cells. (e) Na&#x00EF;ve CTCF ChIP-seq signal from <xref ref-type="bibr" rid="c35">Ji et al. 2016</xref>, centered at TAD boundaries. (f) Number of TADs or differential TADs with cohesin ChIA-PETs within 40kb of boundary.</p></caption>
<graphic xlink:href="181123_fig6.tif"/>
</fig>
</sec>
<sec id="s2g">
<title>3D Genome Architecture in Na&#x00EF;ve hESCs</title>
<p>Genome architecture is an important component of gene regulation. Topological associated domains (TADs) identified in primed hESCs proved to be surprisingly stable upon differentiation to distinct cell types in spite of diverse changes to chromatin structure(<xref ref-type="bibr" rid="c17">Dixon et al., 2015</xref>). Similarly, recent ChIA-PET data for cohesin in primed and na&#x00EF;ve reset cells showed a similar recovery of primed TADs(<xref ref-type="bibr" rid="c35">Ji et al., 2016</xref>). However, domain-scale 3D genome architecture is still missing for the na&#x00EF;ve state. To characterize TADs in na&#x00EF;ve Elf1 2iLIF hESCs, we generated deeply sequenced <italic>in situ</italic> DNase Hi-C maps(<xref ref-type="bibr" rid="c16">Deng et al., 2015</xref>) (Supplementary Figure 7a), which exhibited characteristic reductions in contact frequency as a function of linear distance between two loci (<xref rid="fig6" ref-type="fig">Fig. 6a</xref>). We processed raw Hi-C read pairs produced from H1 primed hESCs(<xref ref-type="bibr" rid="c17">Dixon et al., 2015</xref>; <xref ref-type="bibr" rid="c18">Dixon et al., 2012</xref>) and compared the architectural features identified In each cell type at 40kb resolution. A total of 6,119 TADs were identified in na&#x00EF;ve hESCs compared to 5,822 TADs in primed hESCs (Supplementary Figure 7b), consistent with previous observations in primed hESCs(<xref ref-type="bibr" rid="c61">Shin et al., 2016</xref>). We defined boundaries as regions between two adjacent TADs and found that 7.3&#x0025; and 6.2&#x0025; of boundaries were greater than 40kb in na&#x00EF;ve and primed cells, respectively (Supplementary Figure 7c). To give confidence in our TAD calls, we calculated insulation scores (<xref ref-type="bibr" rid="c13">Crane et al., 2015</xref>; <xref ref-type="bibr" rid="c22">Giorgetti et al., 2016</xref>). Insulation scores are calculated at each Hi-C bin by aggregating the contact measurements in a fixed window around each Hi-C bin. The insulation score represents how insulated each bin is from TAD boundaries. It is expected that TAD boundaries occur at the valleys/minima of insulation scores, and TAD centers occur at the peaks/maxima. We found that boundary insulation scores were significantly different from TAD center scores (<xref rid="fig6" ref-type="fig">Fig. 6b</xref>).</p>
<fig id="fig7" position="float" fig-type="figure">
<label>Figure 7.</label>
<caption><p>(a) Enrichment of ChIP peaks for histone marks H3K4me1, H3K27ac, H3K27me3 and H3K4me3 at overhanging TAD regions. (b) Interaction matrices of region of chr7 containing HOXA locus. Between matrices, horizontal bars with a vertical offset represents an individual TAD, na&#x00EF;ve in navy and primed in orange. The green bar indicates a boundary region &#x003E; 40kb. Track of differential insulation score of na&#x00EF;ve vs. primed cells around the HOXA locus nested in between TAD calls. ChIP-seq signal (RPKM) scaled from 0 to 20 for H3K4me1 and H3K27ac, scaled 0 to 30 for H3K27me3, na&#x00EF;ve in navy and primed in orange. (c) Example of a na&#x00EF;ve-specific A compartment relative to primed. PC1 scale from &#x2212;60 to 60. (d) Heatmap of PC1 values at na&#x00EF;ve- and primed-specific A compartments. PC1 values at randomized compartments are displayed underneath. &#x201C;N&#x201D; and &#x201C;P&#x201D; denote na&#x00EF;ve and primed, respectively. (e) Boxplot of transposable elements expression (RPKM) overlapping A to B compartment switches. &#x201C;A to B&#x201D; and &#x201C;B to A&#x201D; are na&#x00EF;ve to primed directions. Stable are compartments that do not switch. P-values are computed using two-sample t-test with one sided alternative. &#x002A;&#x002A;&#x002A; P-value &#x003C; 2.2 x 10<sup>&#x2212;16</sup>.</p></caption>
<graphic xlink:href="181123_fig7.tif"/>
</fig>
<p>Overall, TAD size distributions are similar (<xref rid="fig6" ref-type="fig">Fig. 6c</xref>, first panel), with means of 420kb in na&#x00EF;ve and 444kb in primed. We observed 2,024 TADs whose genomic coordinates are identical at 40kb resolution while the remaining overlapping TADs differ by at least 40kb (<xref rid="fig6" ref-type="fig">Fig. 6c</xref>, second panel). We asked if the higher number of na&#x00EF;ve Elf1 TADs may be due to better resolution of our <italic>in situ</italic> data, as the two datasets were generated using different Hi-C protocols, and indeed we found that some H1 TADs were split into two or more Elf1 TADs, which accounts for an &#x201C;extra&#x201D; 427 na&#x00EF;ve TADs (Supplementary Figure 7d). The average overlap between na&#x00EF;ve and primed TADs is 319kb, suggesting that the overall TAD structure remains intact between the na&#x00EF;ve and primed states (Supplementary Figure 7e). However, we could detect differences in the location of some TAD boundaries as illustrated by na&#x00EF;ve-specific boundaries exhibiting an enrichment of primed Hi-C signal (<xref rid="fig6" ref-type="fig">Fig. 6d</xref>). That is, in many instances when a change in TAD boundary occurs, this is a shift of the boundary at one end of the TAD relative to the other cell type.</p>
<p>Another group performed cohesin ChIA-PET and CTCF ChIP-seq on primed and reset na&#x00EF;ve hESCs(<xref ref-type="bibr" rid="c67">Theunissen et al., 2014</xref>) which revealed that looping structures can change between the two cell types(<xref ref-type="bibr" rid="c35">Ji et al., 2016</xref>). It was also found that most of the previously published H1 TADs(<xref ref-type="bibr" rid="c17">Dixon et al., 2015</xref>) have a CTCF binding site near their boundaries. We asked if the reset na&#x00EF;ve CTCF ChIP-seq signal was also enriched at TAD boundaries in our na&#x00EF;ve derived hESCs. We found the CTCF signal to be enriched near na&#x00EF;ve boundaries; however, this enrichment was also present for primed hESCs CTCF signal (<xref rid="fig6" ref-type="fig">Fig. 6e</xref>). This is expected as Ji et al. found that 80&#x0025; of CTCF binding sites were common between their reset na&#x00EF;ve and primed hESC lines(<xref ref-type="bibr" rid="c35">Ji et al., 2016</xref>). This helps confirm our <italic>in situ</italic> DNaseI Hi-C data as accurately capturing the 3D structure of the na&#x00EF;ve genome.</p>
<p>Cohesin ChIA-PET data from primed and reset na&#x00EF;ve hESCs could recapitulate Hi-C TADs(<xref ref-type="bibr" rid="c35">Ji et al., 2016</xref>). Although the authors note that their ChIA-PET data were undersaturated,we asked if the cohesin PETs could help to validate our TAD calls. An overlap analysis with cohesin ChIA-PET data yielded 1,363 na&#x00EF;ve and 1,818 primed TADs with at least one PET whose termini are located within 40 kb of each boundary of a given TAD (<xref rid="fig6" ref-type="fig">Fig. 6f</xref>). This corresponds to 22&#x0025; of our na&#x00EF;ve TADs having a na&#x00EF;ve PET and 31&#x0025; of primed TADs having a primed PET within 40kb of the TAD boundary. We looked to see if any of the PETs were near (within 40kb) differential TAD boundaries, those having different boundaries in na&#x00EF;ve and primed of 80kb or greater. Of 1,363 PETs near a na&#x00EF;ve boundary, 529 (39&#x0025;) are near a na&#x00EF;ve differential TAD (<xref rid="fig6" ref-type="fig">Fig. 6f</xref>). This helps confirm some of the structural differences observed in the na&#x00EF;ve 3D genome.</p>
<p>We investigated if there was a relationship between higher-order chromatin structure at differential TAD boundaries and changes in chromatin modifications. We observe a significant enrichment for H3K4me1 and H3K27ac at the internal edge of TADs with differential TAD boundaries in the na&#x00EF;ve state relative to random (na&#x00EF;ve H3K4me1 and H3K27ac P-value &#x003C; 5x10<sup>-5</sup>), and a similar enrichment for primed H3K27me3 (P-value &#x003C; 1x10<sup>-4</sup>) (<xref rid="fig7" ref-type="fig">Fig. 7a</xref>). A clear example illustrating these differences in TAD and chromatin structure is the HOXA cluster, where a broad boundary spans the HOXA cluster in primed hESCs and is enriched for H3K27me3 (<xref rid="fig7" ref-type="fig">Fig. 7b</xref>). In na&#x00EF;ve hESCs, where HOXA genes are expressed, the TAD to the left of the boundary in primed cells is extended across the cluster and marked by H3K4me1 and H3K27ac. We calculated the differential insulation scores by comparing the na&#x00EF;ve minus primed insulation scores to confirm a significant difference in the TAD structures. The differential insulation score represents the differential TAD structure between two samples. We examined the differential insulation score around the HOXA locus (<xref rid="fig7" ref-type="fig">Fig. 7b</xref>), and observed that there was a noticeable decrease in the signal at the HOXA locus, confirming that the TAD structure at the HOXA locus is different between na&#x00EF;ve and primed cells.</p>
<p>Finally, to compare the spatial organization of chromatin within the nuclei of na&#x00EF;ve and primed hESCs, we partitioned the genome into active and inactive (A/B) compartments by performing a PCA of each intra-chromosomal contact matrix(<xref ref-type="bibr" rid="c17">Dixon et al., 2015</xref>; <xref ref-type="bibr" rid="c42">Lieberman-Aiden et al., 2009</xref>). Compartments identified using the first principal component (PC1) ranged in size from 40 kb to over 49 Mb in both cell types, with means of 3.6 Mb in na&#x00EF;ve cells and 3.4 Mb in primed. An overwhelming majority of compartments are static, with only 23 switching from being active in na&#x00EF;ve cells to inactive in primed (A to B), and 124 switching from being active in primed cells to inactive in na&#x00EF;ve (B to A; <xref rid="fig7" ref-type="fig">Fig. 7c,d</xref>). While there is enrichment of primed-specific active compartments, a previous study showed that inactive B sub-compartments are largely devoid of histone modifications, including H3K27me3 and H3K9me3(<xref ref-type="bibr" rid="c55">Rao et al., 2014</xref>). It is therefore likely that the primed-specific active compartments are driven by the lack of repressive modifications in na&#x00EF;ve hESCs (alternatively, these are na&#x00EF;ve-specific inactive B compartments). Additionally, cell-specific active compartments are enriched for TE expression relative to stable compartments (<xref rid="fig7" ref-type="fig">Fig. 7e</xref>), and gene expression to a lesser extent (Supplementary Figure 7f).</p>
</sec>
</sec>
<sec id="s3">
<title>DISCUSSION</title>
<p>Embryogenesis represents the most dynamic epigenetic reprogramming event in mammalian biology. The best illustrative example of this is the erasure of DNA methylation after fertilization that is eventually reestablished upon implantation to prepare the embryo for further development. Coinciding chromatin dynamics upon implantation are largely still unknown. The best supporting evidence that na&#x00EF;ve cells are representative of the pre-implantation embryo is their DNA hypomethylation state, and the corresponding expression of non-coding RNAs such as ERVs and TEs (<xref ref-type="bibr" rid="c23">Grow et al., 2015</xref>; <xref ref-type="bibr" rid="c66">Theunissen et al., 2016</xref>). Thus, na&#x00EF;ve and primed ESCs provide a system to model the transition from the pre- to post-implantation state of the embryo and reveal additional epigenetic changes.</p>
<p>The epigenetic states of embryonic development are also fundamental to our understanding of pluripotency and developmental competency of ESCs. The leading hypothesis for how pluripotency is conferred in ESCs is through a more open chromatin structure relative to other somatic cells, including relative to other stem or progenitor cells (<xref ref-type="bibr" rid="c28">Hawkins et al., 2010</xref>; <xref ref-type="bibr" rid="c34">Hiratani et al., 2010</xref>; <xref ref-type="bibr" rid="c47">Meshorer et al., 2006</xref>). This open chromatin state must, therefore, be derived earlier during embryogenesis. Various new ESC culture conditions now capture different points along the spectrum of pluripotency. Many of which may reflect embryonic stages of development. Our comprehensive chromatin state analyses provide further insight on how na&#x00EF;ve cells are unique from primed hESCs, and exist in a distinctly open chromatin state. A number of recent studies on the genome-wide localization of histone modifications, as well as 3D genome architecture, during mouse embryogenesis provide a framework for a contextual understanding of open chromatin in na&#x00EF;ve hESCs.</p>
<p>During mouse embryogenesis, promoter H3K27me3 accumulates during embryogenesis and implantation (<xref ref-type="bibr" rid="c44">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="c80">Zheng et al., 2016</xref>). The cells of the blastocyst ICM exhibit reduced H3K27me3 as do na&#x00EF;ve (2i-Lif) mESC, while meta-stable mESCs (Lif&#x002B;serum) exhibit an increase of H3K27me3 relative to na&#x00EF;ve mESCs (<xref ref-type="bibr" rid="c80">Zheng et al., 2016</xref>). The depletion of H3K27me3 and far fewer bivalent promoter chromatin states in na&#x00EF;ve hESCs relative to primed cells is consistent with this pre-implantation chromatin signature. We determined 1097 bivalent genes in na&#x00EF;ve hESCs. This is consistent with mouse morula and ICM embryo stages where approximately 1000 and 2000 bivalent gene promoters exist, respectively (<xref ref-type="bibr" rid="c44">Liu et al., 2016</xref>). Another striking similarity is that na&#x00EF;ve bivalent genes are enriched for GO terms related to neurogenesis, which is also true for genes gaining bivalency leading up to mouse ICM formation (<xref ref-type="bibr" rid="c44">Liu et al., 2016</xref>).</p>
<p>Within hours of fertilization of the mouse oocyte, H3K4me1 begins to increase. This initially begins on the paternal genome around five hours post fertilization (p.f.) (<xref ref-type="bibr" rid="c40">Lepikhov and Walter, 2004</xref>), and just after incorporation of histone H3 (<xref ref-type="bibr" rid="c70">van der Heijden et al., 2005</xref>). Increased H3K4me1 coincides with the period of active DNA demethylation of paternal DNA (<xref ref-type="bibr" rid="c57">Santos et al., 2002</xref>), after which H3K4me1 continues to increase on both genomes. Our data show that H3K4me1 has undergone massive expansion in na&#x00EF;ve hESCs relative to primed cells. Although expanded H3K4me1 regions mark known human enhancers, they exist in a poised enhancer chromatin state (H3K4me1), and are decommission upon transition to the primed state, rather than being poised for activation at the next developmental stage.</p>
<p>Enhancer decommissioning, through LSD1 activity, is required for proper ESC differentiation (<xref ref-type="bibr" rid="c73">Whyte et al., 2012</xref>). LSD1 activity is inhibited by acetylation(<xref ref-type="bibr" rid="c20">Forneris et al., 2005</xref>; <xref ref-type="bibr" rid="c39">Lee et al., 2006</xref>) which suggests that de-acetylation must precede the removal H3K4me1 by LSD1. We observed this stepwise decommissioning as cells exited the na&#x00EF;ve state. Recently, ChIP-seq results for H3K27ac in the mouse embryo and serum-maintained mESCs showed enrichment of H3K27ac genome-wide post-ZGA followed by a decline in mESCs(<xref ref-type="bibr" rid="c15">Dahl et al., 2016</xref>). This lends support to our hypothesis that enhancer pre-marking is a likely component of epigenetic reprogramming during embryogenesis.</p>
<p>Because most human TFs are expressed during embryogenesis (<xref ref-type="bibr" rid="c77">Yan et al., 2013</xref>), one hypothesis would be that the increased abundance of H3K4me1 could be the remnants of once active enhancers from earlier in embryogenesis. However, upon resetting primed H1 hESCs to a na&#x00EF;ve state, we found that the expansion of H3K4me1 was gained. This indicates that expansion H3K4me1 domains are a hallmark of the na&#x00EF;ve, pre-implantation state and may have an alternative function.</p>
<p>Because expansion of H3K4me1 across the genome coincides with the hypomethylated DNA state of both na&#x00EF;ve hESCs and the early mouse zygote, we posit that the expansion is either necessary for or aids in maintaining DNA hypomethylation. Although H3K4me3 is primarily cited as the modification being mutually exclusive to DNA methylation, all methylation states of H3K4 (mono-, di-, and tri-) were originally shown to inhibit binding of DNMT3L to the histone H3 tail (<xref ref-type="bibr" rid="c50">Ooi et al., 2007</xref>), which upon binding recruits the <italic>de novo</italic> methyltransferases DNMT3A and 3B. Somewhat paradoxically, our expression data, and that of others, shows that <italic>DNMT3L</italic> is upregulated in na&#x00EF;ve hESCs (<xref ref-type="bibr" rid="c7">Blakeley et al., 2015</xref>; <xref ref-type="bibr" rid="c63">Sperber et al., 2015</xref>). Future studies are needed to understand the interplay between expanding H3K4me1 and DNA demethylation in the pre-implantation state.</p>
<p>Furthermore, the additional depletion of H3K9me3 in the na&#x00EF;ve state signifies an overall dramatic reduction in epigenetic repression relative to primed cells: reduced DNA methylation, H3K27me3 and H3K9me3. Similarly, H3K9me2 is rapidly removed from the maternal genome of the mouse embryo shortly after fertilization (<xref ref-type="bibr" rid="c40">Lepikhov and Walter, 2004</xref>; <xref ref-type="bibr" rid="c58">Sarmento et al., 2004</xref>; <xref ref-type="bibr" rid="c70">van der Heijden et al., 2005</xref>). This is accompanied by hyperacetylation of histones (<xref ref-type="bibr" rid="c1">Adenot et al., 1997</xref>; <xref ref-type="bibr" rid="c76">Wiekowski et al., 1997</xref>). Our data also show an increase in histone acetylation in na&#x00EF;ve state relative to primed. Collectively, these events are likely important in establishing an open chromatin state in the embryo and ESCs.</p>
<p>Na&#x00EF;ve versus primed hESCs illustrate one of the more dramatic changes in chromatin architecture shown between two cell types. We asked if these changes impacted 3D genome structure by generating HiC interaction maps in na&#x00EF;ve hESCs. We found that over 2000 TAD boundaries shifted by at least 80kb between the cell types. As confirmation that the changes reflect biological differences, we found that na&#x00EF;ve-specific boundaries overlap recently published CTCF binding sites from hESCs reset to the na&#x00EF;ve state. However, these sites are also bound by CTCF in primed hESCs, which may suggest the boundaries shift from one CTCF site to another and other factors may control the boundary position. Consistent with this, overlap of recent cohesin ChIA-PET data revealed that of PETs at na&#x00EF;ve TAD boundaries, 39&#x0025; were localized to na&#x00EF;ve-specific boundaries. TAD structures are reported to be stable across cell or tissue type, yet these comparisons also reveal specific TAD boundaries (<xref ref-type="bibr" rid="c18">Dixon et al., 2012</xref>; <xref ref-type="bibr" rid="c59">Schmitt et al., 2016</xref>). Some boundary differences are, therefore, likely expected in any pairwise comparison. In addition, two recent reports showed a gradual, step-wise establishment of TADs during pre-implantation embryogenesis (<xref ref-type="bibr" rid="c19">Du et al., 2017</xref>; <xref ref-type="bibr" rid="c36">Ke et al., 2017</xref>). A comparison of TADs from the mouse ICM to meta-stable mESCs (grown in serum plus Lif) showed 80&#x0025; overlap in TAD boundaries (<xref ref-type="bibr" rid="c19">Du et al., 2017</xref>). Although meta-stable mESCs exist in a state between na&#x00EF;ve and primed, the results suggest that TAD finalization continues into the implantation stage of development. As proof of this, mouse E3.5 and E7.5 embryos continued to show TAD rearrangement relative to each other and previous developmental stages (<xref ref-type="bibr" rid="c36">Ke et al., 2017</xref>). Therefore as in mouse embryogenesis, TAD differences between na&#x00EF;ve and primed hESCs may reflect the continuum of TAD establishment.</p>
<p>In conclusion, na&#x00EF;ve hESCs provide an in vitro model system for studying epigenomic dynamics as cells transition to from the pre- to post-implantation state. This system provides novel insight on this highly dynamic event, and suggest hypotheses that can be tested in mouse, or possibly human, embryos. Furthermore, na&#x00EF;ve cells reveal a more open chromatin state that is likely reflective of earlier epigenomic events during embryogenesis. Human ESC culture conditions provide a tractable system for further investigation of the interplay between epigenomic modifications.</p>
</sec>
<sec id="s4">
<title>MATERIALS AND METHODS</title>
<sec id="s4a">
<title>Human Embryonic Stem Cell Culture</title>
<p>All human ESC culture conditions were as previously described(<xref ref-type="bibr" rid="c63">Sperber et al., 2015</xref>), with the following modifications. Growth conditions: 2iLIF - 1uM Mek inhibitor (PD0325901) [catalog #S1036, Selleck Chemicals, Houston, TX, USA], 1uM GSK3 inhibitor (CHIR-99021) [catalog #S2924, Selleck Chemicals, Houston, TX, USA], 10 ng/mL Leukemia inhibitory factor [catalog #YSP1249, Speed Biosystems, Gaithersburg, MD, USA], 5ng/mL IGF-1 [catalog #100-11 Peprotech, Rocky Hill, NJ], 10ng/mL FGF [catalog #PHG0263, Thermo Fisher Scientific, Waltham, MA, USA]; 4iLIF - 1uM Mek inhibitor (PD0325901), 1uM GSK3 inhibitor (CHIR-99021), 5uM JNK inhibitor (SP600125) [catalog #S1460, Selleck Chemicals, Houston, TX, USA], 2uMp38 inhibitor (BIRB796) [catalog #S1574, Selleck Chemicals, Houston, TX, USA], 10 ng/mL Leukemia inhibitory factor, 5ng/mL IGF-1, 10ng/mL FGF.</p>
</sec>
<sec id="s4b">
<title>Chromatin Immunoprecipitation and Sequencing (ChIP-seq)</title>
<p>ChIP-seq was performed as previously described(<xref ref-type="bibr" rid="c30">Hawkins et al., 2013</xref>). Raw sequence reads from Roadmap Epigenome Project(<xref ref-type="bibr" rid="c29">Hawkins et al., 2011</xref>). All sequenced reads were analyzed with the same pipeline and settings. Sequence reads were aligned to genome (version hg19) using Bowtie2(<xref ref-type="bibr" rid="c38">Langmead and Salzberg, 2012</xref>). Replicates of aligned files were merged prior to peak calling. For the UCSC genome browser tracks, ChIP-seq signals were normalized by RPKM followed by subtraction of input from ChIP using deepTools suite(<xref ref-type="bibr" rid="c54">Ramirez et al., 2014</xref>). Heatmaps and histograms are of normalized ChIP-seq signal: samples are normalized by read count and log2(chip reads/input reads) per 10kb bin is plotted using deepTools suite(<xref ref-type="bibr" rid="c54">Ramirez et al., 2014</xref>).</p>
</sec>
<sec id="s4c">
<title>Peak Calling</title>
<p>ChIP-seq peaks were called on merged replicates and normalized to input using MACS v1.4(<xref ref-type="bibr" rid="c79">Zhang et al., 2008</xref>). Peak calls with a FDR of 5&#x0025; or less were used for downstream analysis. Percent of genome covered was defined as total number of bases under the peak divided by 2.7e9, the effective genome size. This was found it to be a better representation of global chromatin structure (e.g. a 10kb region can be covered by one or many ChIP-seq peaks due to peak size; the number of peaks may vary more than the total number of bases under the peaks). Peak comparisons and overlaps were done using the BedTools suite(<xref ref-type="bibr" rid="c52">Quinlan and Hall, 2010</xref>).</p>
<p>In order to compare the histone marks (H3K4me1 and H3K27ac) across cell types, we divided the genome into 10 kb bins and counted the reads across these 10 kb genomic regions using <italic>featurecounts</italic> in Rsubread package(<xref ref-type="bibr" rid="c41">Liao et al., 2014</xref>). Then, PCA was performed on regularized log transformed read count data obtained using DESeq2(<xref ref-type="bibr" rid="c45">Love et al., 2014</xref>).</p>
</sec>
<sec id="s4d">
<title>RNA-seq and Gene Expression</title>
<p>Embryonic stem cells were counted and 200,000 cells were pelleted for RNA extraction using the Qiagen All Prep Kit (cat 80004). RNA-seq libraries were constructed using the Scriptseq RNA-seq Library Preparation Kit on &#x00BE; of total RNA. Libraries were sequenced single-end 75 on Illumina NextSeq. The quality of the reads and contamination of adapter sequences were checked with FastQC tool (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc/">http://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>). Reads were mapped to human hg19 genome (UCSC) using TopHat2(<xref ref-type="bibr" rid="c37">Kim et al., 2013</xref>). Transcript quantification was performed by Cufflinks(<xref ref-type="bibr" rid="c68">Trapnell et al., 2010</xref>) using GENCODE&#x0027;s comprehensive gene annotation release 19 as reference annotation.</p>
</sec>
<sec id="s4e">
<title>Differential Gene Expression Analysis</title>
<p>The raw read counts were calculated using <italic>featurecounts</italic> in Rsubread package(<xref ref-type="bibr" rid="c41">Liao et al., 2014</xref>) and GENCODE&#x2019;s release 19 as reference annotation. Differential gene expression analysis was performed with DESeq2(<xref ref-type="bibr" rid="c45">Love et al., 2014</xref>) using read counts matrix. Two sets of differentially expressed genes (DEGs) are identified with P-value &#x003C; 0.01, log2FC &#x003E; |1| and P-value &#x003C; 0.01, log2FC &#x003E; |2|. The P-values were adjusted for multiple hypothesis correction. DEGs in all pairwise sample comparisons were identified. PCA was performed on regularized log transformed read count data from autosomes of top 500 highly variant genes obtained using DESeq2(<xref ref-type="bibr" rid="c45">Love et al., 2014</xref>) and plot was generated using ggplot2 in R(<xref ref-type="bibr" rid="c75">Wickham, 2009</xref>). For transposable elements (TE) analysis, transcripts were quantified using hg19 UCSC RepeatMasker TE annotation. We considered unique reads as well as multi mapped reads during quantification of TE transcripts. PCA was performed on regularized log transformed read count data of top 500 highly variant TE transcripts obtained using DESeq2.</p>
</sec>
<sec id="s4f">
<title>Identification of Overrepresented GO Terms and Enriched Pathways</title>
<p>ClueGO(<xref ref-type="bibr" rid="c6">Bindea et al., 2009</xref>) was used to identify the overrepresented GO terms and enriched pathways with the data from gene ontology consortium and KEGG pathways database. The input gene lists to the ClueGO were DEGs with P-value &#x003C; 0.01, log2FC &#x003E; |1|. We used all genes in the genome as background. The statistically significant GO terms and pathways were filtered with P-value &#x003C; 0.05 and GO term/pathway should contain at least 5 DEGs. P-values were adjusted with Benjamini Hochberg method for multiple hypothesis correction.</p>
</sec>
<sec id="s4g">
<title>Sankey Plot</title>
<p>We looked at promoter chromatin state transitions from na&#x00EF;ve to primed to gain insight into the establishment of bivalency and other chromatin state changes occurring at gene promoters. In order to accomplish this goal we focused on the over 19,000 autosomal protein-coding gene TSS annotated by GENCODE. We assigned a promoter to a gene if the H3K4me3 peak was within &#x2212;2kb to &#x002B;500bp of the TSS. Sankey plot is limited by by the presence of multiple promoters. Sankey plot were created using Google Charts (<ext-link ext-link-type="uri" xlink:href="https://developers.google.com/chart/interactive/docs/gallery/sankey">https://developers.google.com/chart/interactive/docs/gallery/sankey</ext-link>)</p>
</sec>
<sec id="s4h">
<title>In situ DNase Hi-C</title>
<p>Samples were prepared in a manner similar to Deng <italic>et al.</italic>, 2015(<xref ref-type="bibr" rid="c16">Deng et al., 2015</xref>). Briefly, nuclei from &#x223C;5 x 10<sup>6</sup> cross-linked Elf1 cells were isolated and permeabilized, and chromatin was digested with 4 U DNase I at room temperature for 4 min. Following end-repair and dA-tailing reactions, chromatin ends were ligated to biotinylated bridge adapters, and nuclei were purified with two volumes of AMPure XP beads (Beckman Coulter). Chromatin ends were phosphorylated and ligated in situ, and protein-DNA cross-links were reversed by proteinase K digestion and incubation at 60&#x00B0;C overnight. Following purification, DNA was sonicated to an average size of 400 bp, and chimeric species were enriched via pull-down with streptavidin-coated magnetic beads (Active Motif). Preparation of Hi-C libraries was accomplished by ligating sequencing adapters to the ends of bead-bound DNA fragments and PCR-amplifying the products in the presence of forward and barcoded reverse primers. Libraries were purified with AMPure XP beads, DNA concentrations were determined using a Qubit 2.0 (Thermo Fisher), and size distributions were quantified using a Bioanalyzer with a high sensitivity kit (Agilent). A 10 ng aliquot from each library was digested with BamHI, run on the Bioanalyzer, and compared to an undigested control in order to confirm the presence of a reconstituted BamHI site at the junctions of ligated bridge adapters.</p>
</sec>
<sec id="s4i">
<title>Hi-C Sequencing and Data Processing</title>
<p>Raw Hi-C sequencing reads from Hi hESCs were downloaded from GEO (GSE35156). Reads were aligned using Bowtie2(<xref ref-type="bibr" rid="c38">Langmead and Salzberg, 2012</xref>) to the hgl9 reference genome and filtered for MAPQ &#x2265; 10, uninformative ligation products, and POR duplicates using HiC-Pro.</p>
<p>Valid Hi-C read pairs from biological replicates of Elf1 and H1 hESCs were combined, respectively, and used to generate raw chromosome-wide interaction matrices binned at a resolution of 40kb. Raw matrices were ICE-normalized using the HiTC Bioconductor package(<xref ref-type="bibr" rid="c60">Servant et al., 2012</xref>) for R, and TADs and boundaries were identified using TopDom(<xref ref-type="bibr" rid="c61">Shin et al., 2016</xref>) with a window size of 5. X and Y chromosomes were removed for the datasets for all Hi-C analyses.</p>
<p>Insulation scores were calculated for the whole of chr7 from the ICE-normalized matrices of both the Elf1 and H1 hESCs, separately. Insulation vectors were detected via cworld(<xref ref-type="bibr" rid="c22">Giorgetti et al., 2016</xref>) using the script matrix2insulation.pl, and using the following options: (--is 240000 -- nt 0.1 --ids 160000 --im median --bmoe 0). Differential insulation scores computing Elf1 score minus H1 score for the whole of chr7 via cworld using the script compareInsulation.pl, with inputs being the two insulation scores above.</p>
<p>High-Confidence SMC1 ChIA-PET interactions for na&#x00EF;ve and primed hESCs were downloaded as a supplemental table(<xref ref-type="bibr" rid="c35">Ji et al., 2016</xref>). A ChIA-PET was considered to span a TAD if both PET termini were located within 40 kb of a TAD boundary.</p>
<p>Spatial compartments and activity status were identified via principal component analysis (PCA) using Homer Tools(<xref ref-type="bibr" rid="c33">Heinz et al., 2010</xref>). Processed Hi-C reads were imported into Homer. For each chromosome, a contact matrix was constructed at 40 kb resolution and normalized using a sliding window of 400 kb as background. Next, the correlation between intra-chromosomal contact profiles was computed and the first principal component (PC1) vector was extracted and saved as a bedGraph file. H3K27ac ChIP-seq peaks served as a seed for determining which regions are active (PC1 &#x003E; 0). A genomic region was considered cell type-specific if it met the following three criteria: 1) the average PC1 value was positive in one cell type and negative in the other, 2) the difference in the average PC1 value was &#x003E; 50 and 3) the correlation between contact profiles was &#x003C; 0.4. Randomization was achieved by selecting coordinates from a pool of 40 kb regions that had associated PC1 values and were not located within any cell type-specific sub-compartments.</p>
</sec>
</sec>
</body>
<back>
<sec id="s5">
<title>ACCESSION NUMBERS</title>
<p>All data will be submitted to Sequence Read Archive (SRA) upon acceptance.</p>
</sec>
<sec id="s6" sec-type="supplementary-material">
<title>SUPPLEMENTAL INFORMATION</title>
<p>Supplementary Information includes 7 figures, and 7 tables.</p>
</sec>
<ack>
<title>ACKNOWLEDGEMENTS</title>
<p>Dr. Gurkan Yardimci (Ph.D., Department of Genome Sciences, University of Washington, Seattle, WA, USA) for communication and advice on Hi-C analysis.</p>
</ack>
<sec id="s7">
<title>AUTHOR CONTRIBUTIONS</title>
<p><bold>COMPETING FINANCIAL INTERESTS</bold></p>
<p><bold>MATERIALS &#x0026; CORRESPONDENCE</bold></p>
</sec>
<ref-list>
<title>REFERENCES</title>
<ref id="c1"><mixed-citation publication-type="journal"><string-name><surname>Adenot</surname>, <given-names>P.G.</given-names></string-name>, <string-name><surname>Mercier</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Renard</surname>, <given-names>J.P.</given-names></string-name>, and <string-name><surname>Thompson</surname>, <given-names>E.M.</given-names></string-name> (<year>1997</year>). <article-title>Differential H4 acetylation of paternal and maternal chromatin precedes DNA replication and differential transcriptional activity in pronuclei of 1-cell mouse embryos</article-title>. <source>Development</source> <volume>124</volume>, <fpage>4615</fpage>&#x2013;<lpage>4625</lpage>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><string-name><surname>Ahmed</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Dehghani</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Rugg-Gunn</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Fussner</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Rossant</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Bazett-Jones</surname>, <given-names>D.P.</given-names></string-name> (<year>2010</year>). <article-title>Global chromatin architecture reflects pluripotency and lineage commitment in the early mouse embryo</article-title>. <source>PLoS One</source> <volume>5</volume>, <fpage>e10531</fpage>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><string-name><surname>Bannister</surname>, <given-names>A.J.</given-names></string-name>, <string-name><surname>Zegerman</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Partridge</surname>, <given-names>J.F.</given-names></string-name>, <string-name><surname>Miska</surname>, <given-names>E.A.</given-names></string-name>, <string-name><surname>Thomas</surname>, <given-names>J.O.</given-names></string-name>, <string-name><surname>Allshire</surname>, <given-names>R.C.</given-names></string-name>, and <string-name><surname>Kouzarides</surname>, <given-names>T.</given-names></string-name> (<year>2001</year>). <article-title>Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain</article-title>. <source>Nature</source> <volume>410</volume>, <fpage>120</fpage>&#x2013;<lpage>124</lpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><string-name><surname>Barski</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Cuddapah</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Cui</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Roh</surname>, <given-names>T.Y.</given-names></string-name>, <string-name><surname>Schones</surname>, <given-names>D.E.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Wei</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Chepelev</surname>, <given-names>I.</given-names></string-name>, and <string-name><surname>Zhao</surname>, <given-names>K.</given-names></string-name> (<year>2007</year>). <article-title>High-resolution profiling of histone methylations in the human genome</article-title>. <source>Cell</source> <volume>129</volume>, <fpage>823</fpage>&#x2013;<lpage>837</lpage>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><string-name><surname>Bernstein</surname>, <given-names>B.E.</given-names></string-name>, <string-name><surname>Mikkelsen</surname>, <given-names>T.S.</given-names></string-name>, <string-name><surname>Xie</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Kamal</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Huebert</surname>, <given-names>D.J.</given-names></string-name>, <string-name><surname>Cuff</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Fry</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Meissner</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Wernig</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Plath</surname>, <given-names>K.</given-names></string-name>, <etal>et al.</etal> (<year>2006</year>). <article-title>A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells</article-title>. <source>Cell</source> <volume>125</volume>, <fpage>315</fpage>&#x2013;<lpage>326</lpage>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><string-name><surname>Bindea</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Mlecnik</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Hackl</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Charoentong</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Tosolini</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kirilovsky</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Fridman</surname>, <given-names>W.H.</given-names></string-name>, <string-name><surname>Pages</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Trajanoski</surname>, <given-names>Z.</given-names></string-name>, and <string-name><surname>Galon</surname>, <given-names>J.</given-names></string-name> (<year>2009</year>). <article-title>ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks</article-title>. <source>Bioinformatics</source> <volume>25</volume>, <fpage>1091</fpage>&#x2013;<lpage>1093</lpage>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><string-name><surname>Blakeley</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Fogarty</surname>, <given-names>N.M.</given-names></string-name>, <string-name><surname>del Valle</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Wamaitha</surname>, <given-names>S.E.</given-names></string-name>, <string-name><surname>Hu</surname>, <given-names>T.X.</given-names></string-name>, <string-name><surname>Elder</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Snell</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Christie</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Robson</surname>, <given-names>P.</given-names></string-name>, and <string-name><surname>Niakan</surname>, <given-names>K.K.</given-names></string-name> (<year>2015</year>). <article-title>Defining the three cell lineages of the human blastocyst by single-cell RNA-seq</article-title>. <source>Development</source> <volume>142</volume>, <fpage>3151</fpage>&#x2013;<lpage>3165</lpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><string-name><surname>Boyer</surname>, <given-names>L.A.</given-names></string-name>, <string-name><surname>Plath</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Zeitlinger</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Brambrink</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Medeiros</surname>, <given-names>L.A.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>T.I.</given-names></string-name>, <string-name><surname>Levine</surname>, <given-names>S.S.</given-names></string-name>, <string-name><surname>Wernig</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Tajonar</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ray</surname>, <given-names>M.K.</given-names></string-name>, <etal>et al.</etal> (<year>2006</year>). <article-title>Polycomb complexes repress developmental regulators in murine embryonic stem cells</article-title>. <source>Nature</source> <volume>441</volume>, <fpage>349</fpage>&#x2013;<lpage>353</lpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><string-name><surname>Brons</surname>, <given-names>I.G.</given-names></string-name>, <string-name><surname>Smithers</surname>, <given-names>L.E.</given-names></string-name>, <string-name><surname>Trotter</surname>, <given-names>M.W.</given-names></string-name>, <string-name><surname>Rugg-Gunn</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Chuva de Sousa Lopes</surname>, <given-names>S.M.</given-names></string-name>, <string-name><surname>Howlett</surname>, <given-names>S.K.</given-names></string-name>, <string-name><surname>Clarkson</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ahrlund-Richter</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Pedersen</surname>, <given-names>R.A.</given-names></string-name>, <etal>et al.</etal> (<year>2007</year>). <article-title>Derivation of pluripotent epiblast stem cells from mammalian embryos</article-title>. <source>Nature</source> <volume>448</volume>, <fpage>191</fpage>&#x2013;<lpage>195</lpage>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><string-name><surname>Chan</surname>, <given-names>Y.S.</given-names></string-name>, <string-name><surname>Goke</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Ng</surname>, <given-names>J.H.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Gonzales</surname>, <given-names>K.A.</given-names></string-name>, <string-name><surname>Tan</surname>, <given-names>C.P.</given-names></string-name>, <string-name><surname>Tng</surname>, <given-names>W.Q.</given-names></string-name>, <string-name><surname>Hong</surname>, <given-names>Z.Z.</given-names></string-name>, <string-name><surname>Lim</surname>, <given-names>Y.S.</given-names></string-name>, and <string-name><surname>Ng</surname>, <given-names>H.H.</given-names></string-name> (<year>2013</year>). <article-title>Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast</article-title>. <source>Cell Stem Cell</source> <volume>13</volume>, <fpage>663</fpage>&#x2013;<lpage>675</lpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><string-name><surname>Chen</surname>, <given-names>Y.-G.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Z.</given-names></string-name>, and <string-name><surname>Wang</surname>, <given-names>X.-F.</given-names></string-name> (<year>2012</year>). <article-title>Where PI3K/Akt Meets Smads: The Crosstalk Determines Human Embryonic Stem Cell Fate</article-title>. <source>Cell Stem Cell</source> <volume>10</volume>, <fpage>231</fpage>&#x2013;<lpage>232</lpage>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><string-name><surname>Consortium</surname>, <given-names>E.</given-names></string-name> (<year>2012</year>). <article-title>An integrated encyclopedia of DNA elements in the human genome</article-title>. <source>Nature</source> <volume>489</volume>, <fpage>57</fpage>&#x2013;<lpage>74</lpage>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><string-name><surname>Crane</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Bian</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>McCord</surname>, <given-names>R.P.</given-names></string-name>, <string-name><surname>Lajoie</surname>, <given-names>B.R.</given-names></string-name>, <string-name><surname>Wheeler</surname>, <given-names>B.S.</given-names></string-name>, <string-name><surname>Ralston</surname>, <given-names>E.J.</given-names></string-name>, <string-name><surname>Uzawa</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Dekker</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Meyer</surname>, <given-names>B.J.</given-names></string-name> (<year>2015</year>). <article-title>Condensin-driven remodelling of X chromosome topology during dosage compensation</article-title>. <source>Nature</source> <volume>523</volume>, <fpage>240</fpage>&#x2013;<lpage>244</lpage>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><string-name><surname>Creyghton</surname>, <given-names>M.P.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>A.W.</given-names></string-name>, <string-name><surname>Welstead</surname>, <given-names>G.G.</given-names></string-name>, <string-name><surname>Kooistra</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Carey</surname>, <given-names>B.W.</given-names></string-name>, <string-name><surname>Steine</surname>, <given-names>E.J.</given-names></string-name>, <string-name><surname>Hanna</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Lodato</surname>, <given-names>M.A.</given-names></string-name>, <string-name><surname>Frampton</surname>, <given-names>G.M.</given-names></string-name>, <string-name><surname>Sharp</surname>, <given-names>P.A.</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>). <article-title>Histone H3K27ac separates active from poised enhancers and predicts developmental state</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>107</volume>, <fpage>21931</fpage>&#x2013;<lpage>21936</lpage>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><string-name><surname>Dahl</surname>, <given-names>J.A.</given-names></string-name>, <string-name><surname>Jung</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Aanes</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Greggains</surname>, <given-names>G.D.</given-names></string-name>, <string-name><surname>Manaf</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lerdrup</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Kuan</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>A.Y.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title>Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition</article-title>. <source>Nature</source> <volume>537</volume>, <fpage>548</fpage>&#x2013;<lpage>552</lpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><string-name><surname>Deng</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Ramani</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Hill</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Ay</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Berletch</surname>, <given-names>J.B.</given-names></string-name>, <string-name><surname>Blau</surname>, <given-names>C.A.</given-names></string-name>, <string-name><surname>Shendure</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Duan</surname>, <given-names>Z.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title>Bipartite structure of the inactive mouse X chromosome</article-title>. <source>Genome Biol</source> <volume>16</volume>, <fpage>152</fpage>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><string-name><surname>Dixon</surname>, <given-names>J.R.</given-names></string-name>, <string-name><surname>Jung</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Selvaraj</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Shen</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Antosiewicz-Bourget</surname>, <given-names>J.E.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>A.Y.</given-names></string-name>, <string-name><surname>Ye</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Rajagopal</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Xie</surname>, <given-names>W.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title>Chromatin architecture reorganization during stem cell differentiation</article-title>. <source>Nature</source> <volume>518</volume>, <fpage>331</fpage>&#x2013;<lpage>336</lpage>.</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><string-name><surname>Dixon</surname>, <given-names>J.R.</given-names></string-name>, <string-name><surname>Selvaraj</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Yue</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Shen</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Hu</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>J.S.</given-names></string-name>, and <string-name><surname>Ren</surname>, <given-names>B.</given-names></string-name> (<year>2012</year>). <article-title>Topological domains in mammalian genomes identified by analysis of chromatin interactions</article-title>. <source>Nature</source> <volume>485</volume>, <fpage>376</fpage>&#x2013;<lpage>380</lpage>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><string-name><surname>Du</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Zheng</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Xiang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>). <article-title>Allelic reprogramming of 3D chromatin architecture during early mammalian development</article-title>. <source>Nature</source> <volume>547</volume>, <fpage>232</fpage>&#x2013;<lpage>235</lpage>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><string-name><surname>Forneris</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Binda</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Vanoni</surname>, <given-names>M.A.</given-names></string-name>, <string-name><surname>Battaglioli</surname>, <given-names>E.</given-names></string-name>, and <string-name><surname>Mattevi</surname>, <given-names>A.</given-names></string-name> (<year>2005</year>). <article-title>Human Histone Demethylase LSD1 Reads the Histone Code</article-title>. <source>The Journal of Biological Chemistry</source>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><string-name><surname>Gafni</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Weinberger</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Mansour</surname>, <given-names>A.A.</given-names></string-name>, <string-name><surname>Manor</surname>, <given-names>Y.S.</given-names></string-name>, <string-name><surname>Chomsky</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Ben-Yosef</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Kalma</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Viukov</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Maza</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Zviran</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>). <article-title>Derivation of novel human ground state naive pluripotent stem cells</article-title>. <source>Nature</source> <volume>504</volume>, <fpage>282</fpage>&#x2013;<lpage>286</lpage>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><string-name><surname>Giorgetti</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Lajoie</surname>, <given-names>B.R.</given-names></string-name>, <string-name><surname>Carter</surname>, <given-names>A.C.</given-names></string-name>, <string-name><surname>Attia</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zhan</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>C.J.</given-names></string-name>, <string-name><surname>Kaplan</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>H.Y.</given-names></string-name>, <string-name><surname>Heard</surname>, <given-names>E.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title>Structural organization of the inactive X chromosome in the mouse</article-title>. <source>Nature</source> <volume>535</volume>, <fpage>575</fpage>&#x2013;<lpage>579</lpage>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><string-name><surname>Grow</surname>, <given-names>E.J.</given-names></string-name>, <string-name><surname>Flynn</surname>, <given-names>R.A.</given-names></string-name>, <string-name><surname>Chavez</surname>, <given-names>S.L.</given-names></string-name>, <string-name><surname>Bayless</surname>, <given-names>N.L.</given-names></string-name>, <string-name><surname>Wossidlo</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Wesche</surname>, <given-names>D.J.</given-names></string-name>, <string-name><surname>Martin</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Ware</surname>, <given-names>C.B.</given-names></string-name>, <string-name><surname>Blish</surname>, <given-names>C.A.</given-names></string-name>, <string-name><surname>Chang</surname>, <given-names>H.Y.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title>Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells</article-title>. <source>Nature</source> <volume>522</volume>, <fpage>221</fpage>&#x2013;<lpage>225</lpage>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><string-name><surname>Guenther</surname>, <given-names>M.G.</given-names></string-name>, <string-name><surname>Levine</surname>, <given-names>S.S.</given-names></string-name>, <string-name><surname>Boyer</surname>, <given-names>L.A.</given-names></string-name>, <string-name><surname>Jaenisch</surname>, <given-names>R.</given-names></string-name>, and <string-name><surname>Young</surname>, <given-names>R.A.</given-names></string-name> (<year>2007</year>). <article-title>A chromatin landmark and transcription initiation at most promoters in human cells</article-title>. <source>Cell</source> <volume>130</volume>, <fpage>77</fpage>&#x2013;<lpage>88</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><string-name><surname>Guo</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>von Meyenn</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Santos</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Reik</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Bertone</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Nichols</surname>, <given-names>J.</given-names></string-name> (<year>2016</year>). <article-title>Naive Pluripotent Stem Cells Derived Directly from Isolated Cells of the Human Inner Cell Mass</article-title>. <source>Stem Cell Reports</source> <volume>6</volume>, <fpage>437</fpage>&#x2013;<lpage>446</lpage>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><string-name><surname>Guo</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Zhu</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Hu</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Lian</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Ren</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>J.</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title>The DNA methylation landscape of human early embryos</article-title>. <source>Nature</source> <volume>511</volume>, <fpage>606</fpage>&#x2013;<lpage>610</lpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><string-name><surname>Hanna</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>A.W.</given-names></string-name>, <string-name><surname>Saha</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Lengner</surname>, <given-names>C.J.</given-names></string-name>, <string-name><surname>Soldner</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Cassady</surname>, <given-names>J.P.</given-names></string-name>, <string-name><surname>Muffat</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Carey</surname>, <given-names>B.W.</given-names></string-name>, and <string-name><surname>Jaenisch</surname>, <given-names>R.</given-names></string-name> (<year>2010</year>). <article-title>Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>107</volume>, <fpage>9222</fpage>&#x2013;<lpage>9227</lpage>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><string-name><surname>Hawkins</surname>, <given-names>R.D.</given-names></string-name>, <string-name><surname>Hon</surname>, <given-names>G.C.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>L.K.</given-names></string-name>, <string-name><surname>Ngo</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Lister</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Pelizzola</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Edsall</surname>, <given-names>L.E.</given-names></string-name>, <string-name><surname>Kuan</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Luu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Klugman</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>). <article-title>Distinct epigenomic landscapes of pluripotent and lineage-committed human cells</article-title>. <source>Cell Stem Cell</source> <volume>6</volume>, <fpage>479</fpage>&#x2013;<lpage>491</lpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><string-name><surname>Hawkins</surname>, <given-names>R.D.</given-names></string-name>, <string-name><surname>Hon</surname>, <given-names>G.C.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Antosiewicz-Bourget</surname>, <given-names>J.E.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>L.K.</given-names></string-name>, <string-name><surname>Ngo</surname>, <given-names>Q.M.</given-names></string-name>, <string-name><surname>Klugman</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ching</surname>, <given-names>K.A.</given-names></string-name>, <string-name><surname>Edsall</surname>, <given-names>L.E.</given-names></string-name>, <string-name><surname>Ye</surname>, <given-names>Z.</given-names></string-name>, <etal>et al.</etal> (<year>2011</year>). <article-title>Dynamic chromatin states in human ES cells reveal potential regulatory sequences and genes involved in pluripotency</article-title>. <source>Cell Res</source> <volume>21</volume>, <fpage>1393</fpage>&#x2013;<lpage>1409</lpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><string-name><surname>Hawkins</surname>, <given-names>R.D.</given-names></string-name>, <string-name><surname>Larjo</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Tripathi</surname>, <given-names>S.K.</given-names></string-name>, <string-name><surname>Wagner</surname>, <given-names>U.</given-names></string-name>, <string-name><surname>Luu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Lonnberg</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Raghav</surname>, <given-names>S.K.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>L.K.</given-names></string-name>, <string-name><surname>Lund</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ren</surname>, <given-names>B.</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>). <article-title>Global chromatin state analysis reveals lineage-specific enhancers during the initiation of human T helper 1 and T helper 2 cell polarization</article-title>. <source>Immunity</source> <volume>38</volume>, <fpage>1271</fpage>&#x2013;<lpage>1284</lpage>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><string-name><surname>Heintzman</surname>, <given-names>N.D.</given-names></string-name>, <string-name><surname>Hon</surname>, <given-names>G.C.</given-names></string-name>, <string-name><surname>Hawkins</surname>, <given-names>R.D.</given-names></string-name>, <string-name><surname>Kheradpour</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Stark</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Harp</surname>, <given-names>L.F.</given-names></string-name>, <string-name><surname>Ye</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>L.K.</given-names></string-name>, <string-name><surname>Stuart</surname>, <given-names>R.K.</given-names></string-name>, <string-name><surname>Ching</surname>, <given-names>C.W.</given-names></string-name>, <etal>et al.</etal> (<year>2009</year>). <article-title>Histone modifications at human enhancers reflect global cell-type-specific gene expression</article-title>. <source>Nature</source> <volume>459</volume>, <fpage>108</fpage>&#x2013;<lpage>112</lpage>.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><string-name><surname>Heintzman</surname>, <given-names>N.D.</given-names></string-name>, <string-name><surname>Stuart</surname>, <given-names>R.K.</given-names></string-name>, <string-name><surname>Hon</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Fu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Ching</surname>, <given-names>C.W.</given-names></string-name>, <string-name><surname>Hawkins</surname>, <given-names>R.D.</given-names></string-name>, <string-name><surname>Barrera</surname>, <given-names>L.O.</given-names></string-name>, <string-name><surname>Van Calcar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Qu</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Ching</surname>, <given-names>K.A.</given-names></string-name>, <etal>et al.</etal> (<year>2007</year>). <article-title>Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome</article-title>. <source>Nat Genet</source> <volume>39</volume>, <fpage>311</fpage>&#x2013;<lpage>318</lpage>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><string-name><surname>Heinz</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Benner</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Spann</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Bertolino</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>Y.C.</given-names></string-name>, <string-name><surname>Laslo</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Cheng</surname>, <given-names>J.X.</given-names></string-name>, <string-name><surname>Murre</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Singh</surname>, <given-names>H.</given-names></string-name>, and <string-name><surname>Glass</surname>, <given-names>C.K.</given-names></string-name> (<year>2010</year>). <article-title>Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities</article-title>. <source>Mol Cell</source> <volume>38</volume>, <fpage>576</fpage>&#x2013;<lpage>589</lpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><string-name><surname>Hiratani</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Ryba</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Itoh</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Rathjen</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kulik</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Papp</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Fussner</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Bazett-Jones</surname>, <given-names>D.P.</given-names></string-name>, <string-name><surname>Plath</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Dalton</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>). <article-title>Genome-wide dynamics of replication timing revealed by in vitro models of mouse embryogenesis</article-title>. <source>Genome Res</source> <volume>20</volume>, <fpage>155</fpage>&#x2013;<lpage>169</lpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><string-name><surname>Ji</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Dadon</surname>, <given-names>D.B.</given-names></string-name>, <string-name><surname>Powell</surname>, <given-names>B.E.</given-names></string-name>, <string-name><surname>Fan</surname>, <given-names>Z.P.</given-names></string-name>, <string-name><surname>Borges-Rivera</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Shachar</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Weintraub</surname>, <given-names>A.S.</given-names></string-name>, <string-name><surname>Hnisz</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Pegoraro</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>T.I.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title>3D Chromosome Regulatory Landscape of Human Pluripotent Cells</article-title>. <source>Cell Stem Cell</source> <volume>18</volume>, <fpage>262</fpage>&#x2013;<lpage>275</lpage>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><string-name><surname>Ke</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Feng</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Yao</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Zhu</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Gao</surname>, <given-names>L.</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>). <article-title>3D Chromatin Structures of Mature Gametes and Structural Reprogramming during Mammalian Embryogenesis</article-title>. <source>Cell</source> <volume>170</volume>, <fpage>367</fpage>&#x2013;<lpage>381</lpage>.e320.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Pertea</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Trapnell</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Pimentel</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kelley</surname>, <given-names>R.</given-names></string-name>, and <string-name><surname>Salzberg</surname>, <given-names>S.L.</given-names></string-name> (<year>2013</year>). <article-title>TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title>. <source>Genome Biol</source> <volume>14</volume>, <fpage>R36</fpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><string-name><surname>Langmead</surname>, <given-names>B.</given-names></string-name>, and <string-name><surname>Salzberg</surname>, <given-names>S.L.</given-names></string-name> (<year>2012</year>). <article-title>Fast gapped-read alignment with Bowtie 2</article-title>. <source>Nat Methods</source> <volume>9</volume>, <fpage>357</fpage>&#x2013;<lpage>359</lpage>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><string-name><surname>Lee</surname>, <given-names>M.G.</given-names></string-name>, <string-name><surname>Wynder</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Bochar</surname>, <given-names>D.A.</given-names></string-name>, <string-name><surname>Hakimi</surname>, <given-names>M.A.</given-names></string-name>, <string-name><surname>Cooch</surname>, <given-names>N.</given-names></string-name>, and <string-name><surname>Shiekhattar</surname>, <given-names>R.</given-names></string-name> (<year>2006</year>). <article-title>Functional Interplay between Histone Demethylase and Deacetylase Enzymes</article-title>. In <source>Mol Cell Biol</source>, pp. <fpage>6395</fpage>&#x2013;<lpage>6402</lpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><string-name><surname>Lepikhov</surname>, <given-names>K.</given-names></string-name>, and <string-name><surname>Walter</surname>, <given-names>J.</given-names></string-name> (<year>2004</year>). <article-title>Differential dynamics of histone H3 methylation at positions K4 and K9 in the mouse zygote</article-title>. <source>BMC Dev Biol</source> <volume>4</volume>, <fpage>12</fpage>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><string-name><surname>Liao</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Smyth</surname>, <given-names>G.K.</given-names></string-name>, and <string-name><surname>Shi</surname>, <given-names>W.</given-names></string-name> (<year>2014</year>). <article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title>. <source>Bioinformatics</source> <volume>30</volume>, <fpage>923</fpage>&#x2013;<lpage>930</lpage>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><string-name><surname>Lieberman-Aiden</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>van Berkum</surname>, <given-names>N.L.</given-names></string-name>, <string-name><surname>Williams</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Imakaev</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ragoczy</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Telling</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Amit</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Lajoie</surname>, <given-names>B.R.</given-names></string-name>, <string-name><surname>Sabo</surname>, <given-names>P.J.</given-names></string-name>, <string-name><surname>Dorschner</surname>, <given-names>M.O.</given-names></string-name>, <etal>et al.</etal> (<year>2009</year>). <article-title>Comprehensive mapping of long-range interactions reveals folding principles of the human genome</article-title>. <source>Science</source> <volume>326</volume>, <fpage>289</fpage>&#x2013;<lpage>293</lpage>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kim</surname>, <given-names>J.M.</given-names></string-name>, and <string-name><surname>Aoki</surname>, <given-names>F.</given-names></string-name> (<year>2004</year>). <article-title>Regulation of histone H3 lysine 9 methylation in oocytes and early pre-implantation embryos</article-title>. <source>Development</source> <volume>131</volume>, <fpage>2269</fpage>&#x2013;<lpage>2280</lpage>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Kou</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Gao</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title>Distinct features of H3K4me3 and H3K27me3 chromatin domains in pre-implantation embryos</article-title>. <source>Nature</source> <volume>537</volume>, <fpage>558</fpage>&#x2013;<lpage>562</lpage>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><string-name><surname>Love</surname>, <given-names>M.I.</given-names></string-name>, <string-name><surname>Huber</surname>, <given-names>W.</given-names></string-name>, and <string-name><surname>Anders</surname>, <given-names>S.</given-names></string-name> (<year>2014</year>). <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol</source> <volume>15</volume>, <fpage>550</fpage>.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><string-name><surname>Marks</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Kalkan</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Menafra</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Denissov</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Jones</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Hofemeister</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Nichols</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kranz</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Stewart</surname>, <given-names>A.F.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title>The transcriptional and epigenomic foundations of ground state pluripotency</article-title>. <source>Cell</source> <volume>149</volume>, <fpage>590</fpage>&#x2013;<lpage>604</lpage>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><string-name><surname>Meshorer</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Yellajoshula</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>George</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Scambler</surname>, <given-names>P.J.</given-names></string-name>, <string-name><surname>Brown</surname>, <given-names>D.T.</given-names></string-name>, and <string-name><surname>Misteli</surname>, <given-names>T.</given-names></string-name> (<year>2006</year>). <article-title>Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells</article-title>. <source>Dev Cell</source> <volume>10</volume>, <fpage>105</fpage>&#x2013;<lpage>116</lpage>.</mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><string-name><surname>Niakan</surname>, <given-names>K.K.</given-names></string-name>, and <string-name><surname>Eggan</surname>, <given-names>K.</given-names></string-name> (<year>2013</year>). <article-title>Analysis of human embryos from zygote to blastocyst reveals distinct gene expression patterns relative to the mouse</article-title>. <source>Dev Biol</source> <volume>375</volume>, <fpage>54</fpage>&#x2013;<lpage>64</lpage>.</mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><string-name><surname>Nichols</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Smith</surname>, <given-names>A.</given-names></string-name> (<year>2009</year>). <article-title>Naive and primed pluripotent states</article-title>. <source>Cell Stem Cell</source> <volume>4</volume>, <fpage>487</fpage>&#x2013;<lpage>492</lpage>.</mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><string-name><surname>Ooi</surname>, <given-names>S.K.</given-names></string-name>, <string-name><surname>Qiu</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Bernstein</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Jia</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Erdjument-Bromage</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Tempst</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>S.P.</given-names></string-name>, <string-name><surname>Allis</surname>, <given-names>C.D.</given-names></string-name>, <etal>et al.</etal> (<year>2007</year>). <article-title>DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA</article-title>. <source>Nature</source> <volume>448</volume>, <fpage>714</fpage>&#x2013;<lpage>717</lpage>.</mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><string-name><surname>Parker</surname>, <given-names>S.C.</given-names></string-name>, <string-name><surname>Stitzel</surname>, <given-names>M.L.</given-names></string-name>, <string-name><surname>Taylor</surname>, <given-names>D.L.</given-names></string-name>, <string-name><surname>Orozco</surname>, <given-names>J.M.</given-names></string-name>, <string-name><surname>Erdos</surname>, <given-names>M.R.</given-names></string-name>, <string-name><surname>Akiyama</surname>, <given-names>J.A.</given-names></string-name>, <string-name><surname>van Bueren</surname>, <given-names>K.L.</given-names></string-name>, <string-name><surname>Chines</surname>, <given-names>P.S.</given-names></string-name>, <string-name><surname>Narisu</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Black</surname>, <given-names>B.L.</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>). <article-title>Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>110</volume>, <fpage>17921</fpage>&#x2013;<lpage>17926</lpage>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><string-name><surname>Quinlan</surname>, <given-names>A.R.</given-names></string-name>, and <string-name><surname>Hall</surname>, <given-names>I.M.</given-names></string-name> (<year>2010</year>). <article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>. In <source>Bioinformatics</source>, pp. <fpage>841</fpage>&#x2013;<lpage>842</lpage>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><string-name><surname>Rada-Iglesias</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bajpai</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Swigut</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Brugmann</surname>, <given-names>S.A.</given-names></string-name>, <string-name><surname>Flynn</surname>, <given-names>R.A.</given-names></string-name>, and <string-name><surname>Wysocka</surname>, <given-names>J.</given-names></string-name> (<year>2011</year>). <article-title>A unique chromatin signature uncovers early developmental enhancers in humans</article-title>. <source>Nature</source> <volume>470</volume>, <fpage>279</fpage>&#x2013;<lpage>283</lpage>.</mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><string-name><surname>Ramirez</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Dundar</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Diehl</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Gruning</surname>, <given-names>B.A.</given-names></string-name>, and <string-name><surname>Manke</surname>, <given-names>T.</given-names></string-name> (<year>2014</year>). <article-title>deepTools: a flexible platform for exploring deep-sequencing data</article-title>. <source>Nucleic Acids Res</source> <volume>42</volume>, <fpage>W187</fpage>&#x2013;<lpage>191</lpage>.</mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><string-name><surname>Rao</surname>, <given-names>S.S.</given-names></string-name>, <string-name><surname>Huntley</surname>, <given-names>M.H.</given-names></string-name>, <string-name><surname>Durand</surname>, <given-names>N.C.</given-names></string-name>, <string-name><surname>Stamenova</surname>, <given-names>E.K.</given-names></string-name>, <string-name><surname>Bochkov</surname>, <given-names>I.D.</given-names></string-name>, <string-name><surname>Robinson</surname>, <given-names>J.T.</given-names></string-name>, <string-name><surname>Sanborn</surname>, <given-names>A.L.</given-names></string-name>, <string-name><surname>Machol</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Omer</surname>, <given-names>A.D.</given-names></string-name>, <string-name><surname>Lander</surname>, <given-names>E.S.</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title>A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping</article-title>. <source>Cell</source> <volume>159</volume>, <fpage>1665</fpage>&#x2013;<lpage>1680</lpage>.</mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><string-name><surname>Rossant</surname>, <given-names>J.</given-names></string-name> (<year>2015</year>). <article-title>Mouse and human blastocyst-derived stem cells: vive les differences</article-title>. <source>Development</source> <volume>142</volume>, <fpage>9</fpage>&#x2013;<lpage>12</lpage>.</mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><string-name><surname>Santos</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Hendrich</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Reik</surname>, <given-names>W.</given-names></string-name>, and <string-name><surname>Dean</surname>, <given-names>W.</given-names></string-name> (<year>2002</year>). <article-title>Dynamic reprogramming of DNA methylation in the early mouse embryo</article-title>. <source>Dev Biol</source> <volume>241</volume>, <fpage>172</fpage>&#x2013;<lpage>182</lpage>.</mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><string-name><surname>Sarmento</surname>, <given-names>O.F.</given-names></string-name>, <string-name><surname>Digilio</surname>, <given-names>L.C.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Perlin</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Herr</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Allis</surname>, <given-names>C.D.</given-names></string-name>, and <string-name><surname>Coonrod</surname>, <given-names>S.A.</given-names></string-name> (<year>2004</year>). <article-title>Dynamic alterations of specific histone modifications during early murine development</article-title>. <source>J Cell Sci</source> <volume>117</volume>, <fpage>4449</fpage>&#x2013;<lpage>4459</lpage>.</mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><string-name><surname>Schmitt</surname>, <given-names>A.D.</given-names></string-name>, <string-name><surname>Hu</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Jung</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Qiu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Tan</surname>, <given-names>C.L.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Barr</surname>, <given-names>C.L.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title>A Compendium of Chromatin Contact Maps Reveals Spatially Active Regions in the Human Genome</article-title>. <source>Cell Rep</source> <volume>17</volume>, <fpage>2042</fpage>&#x2013;<lpage>2059</lpage>.</mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><string-name><surname>Servant</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Lajoie</surname>, <given-names>B.R.</given-names></string-name>, <string-name><surname>Nora</surname>, <given-names>E.P.</given-names></string-name>, <string-name><surname>Giorgetti</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>C.J.</given-names></string-name>, <string-name><surname>Heard</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Dekker</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Barillot</surname>, <given-names>E.</given-names></string-name> (<year>2012</year>). <article-title>HiTC: exploration of high-throughput &#x0027;C&#x0027; experiments</article-title>. <source>Bioinformatics</source> <volume>28</volume>, <fpage>2843</fpage>&#x2013;<lpage>2844</lpage>.</mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><string-name><surname>Shin</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Shi</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Dai</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Tjong</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Gong</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Alber</surname>, <given-names>F.</given-names></string-name>, and <string-name><surname>Zhou</surname>, <given-names>X.J.</given-names></string-name> (<year>2016</year>). <article-title>TopDom: an efficient and deterministic method for identifying topological domains in genomes</article-title>. <source>Nucleic Acids Res</source> <volume>44</volume>, <fpage>e70</fpage>.</mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><string-name><surname>Silva</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>Smith</surname>, <given-names>A.</given-names></string-name> (<year>2008</year>). <article-title>Capturing pluripotency</article-title>. <source>Cell</source> <volume>132</volume>, <fpage>532</fpage>&#x2013;<lpage>536</lpage>.</mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><string-name><surname>Sperber</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Mathieu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Ferreccio</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hesson</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Fischer</surname>, <given-names>K.A.</given-names></string-name>, <string-name><surname>Devi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Detraux</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Gu</surname>, <given-names>H.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title>The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition</article-title>. <source>Nat Cell Biol</source> <volume>17</volume>, <fpage>1523</fpage>&#x2013;<lpage>1535</lpage>.</mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><string-name><surname>Takashima</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Guo</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Loos</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Nichols</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Ficz</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Krueger</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Oxley</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Santos</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Clarke</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Mansfield</surname>, <given-names>W.</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title>Resetting transcription factor control circuitry toward ground-state pluripotency in human</article-title>. <source>Cell</source> <volume>158</volume>, <fpage>1254</fpage>&#x2013;<lpage>1269</lpage>.</mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><string-name><surname>Tesar</surname>, <given-names>P.J.</given-names></string-name>, <string-name><surname>Chenoweth</surname>, <given-names>J.G.</given-names></string-name>, <string-name><surname>Brook</surname>, <given-names>F.A.</given-names></string-name>, <string-name><surname>Davies</surname>, <given-names>T.J.</given-names></string-name>, <string-name><surname>Evans</surname>, <given-names>E.P.</given-names></string-name>, <string-name><surname>Mack</surname>, <given-names>D.L.</given-names></string-name>, <string-name><surname>Gardner</surname>, <given-names>R.L.</given-names></string-name>, and <string-name><surname>McKay</surname>, <given-names>R.D.</given-names></string-name> (<year>2007</year>). <article-title>New cell lines from mouse epiblast share defining features with human embryonic stem cells</article-title>. <source>Nature</source> <volume>448</volume>, <fpage>196</fpage>&#x2013;<lpage>199</lpage>.</mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><string-name><surname>Theunissen</surname>, <given-names>T.W.</given-names></string-name>, <string-name><surname>Friedli</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>He</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Planet</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>O&#x0027;Neil</surname>, <given-names>R.C.</given-names></string-name>, <string-name><surname>Markoulaki</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Pontis</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Iouranova</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Imbeault</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title>Molecular Criteria for Defining the Naive Human Pluripotent State</article-title>. <source>Cell Stem Cell</source> <volume>19</volume>, <fpage>502</fpage>&#x2013;<lpage>515</lpage>.</mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><string-name><surname>Theunissen</surname>, <given-names>T.W.</given-names></string-name>, <string-name><surname>Powell</surname>, <given-names>B.E.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Mitalipova</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Faddah</surname>, <given-names>D.A.</given-names></string-name>, <string-name><surname>Reddy</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Fan</surname>, <given-names>Z.P.</given-names></string-name>, <string-name><surname>Maetzel</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Ganz</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Shi</surname>, <given-names>L.</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title>Systematic identification of culture conditions for induction and maintenance of naive human pluripotency</article-title>. <source>Cell Stem Cell</source> <volume>15</volume>, <fpage>471</fpage>&#x2013;<lpage>487</lpage>.</mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><string-name><surname>Trapnell</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Williams</surname>, <given-names>B.A.</given-names></string-name>, <string-name><surname>Pertea</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Mortazavi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kwan</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>van Baren</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>Salzberg</surname>, <given-names>S.L.</given-names></string-name>, <string-name><surname>Wold</surname>, <given-names>B.J.</given-names></string-name>, and <string-name><surname>Pachter</surname>, <given-names>L.</given-names></string-name> (<year>2010</year>). <article-title>Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation</article-title>. <source>Nat Biotechnol</source> <volume>28</volume>, <fpage>511</fpage>&#x2013;<lpage>515</lpage>.</mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><string-name><surname>Valamehr</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Robinson</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Abujarour</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Rezner</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Vranceanu</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Le</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Medcalf</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>T.T.</given-names></string-name>, <string-name><surname>Fitch</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Robbins</surname>, <given-names>D.</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title>Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells</article-title>. <source>Stem Cell Reports</source> <volume>2</volume>, <fpage>366</fpage>&#x2013;<lpage>381</lpage>.</mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><string-name><surname>van der Heijden</surname>, <given-names>G.W.</given-names></string-name>, <string-name><surname>Dieker</surname>, <given-names>J.W.</given-names></string-name>, <string-name><surname>Derijck</surname>, <given-names>A.A.</given-names></string-name>, <string-name><surname>Muller</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Berden</surname>, <given-names>J.H.</given-names></string-name>, <string-name><surname>Braat</surname>, <given-names>D.D.</given-names></string-name>, <string-name><surname>van der Vlag</surname>, <given-names>J.</given-names></string-name>, and <string-name><surname>de Boer</surname>, <given-names>P.</given-names></string-name> (<year>2005</year>). <article-title>Asymmetry in histone H3 variants and lysine methylation between paternal and maternal chromatin of the early mouse zygote</article-title>. <source>Mech Dev</source> <volume>122</volume>, <fpage>1008</fpage>&#x2013;<lpage>1022</lpage>.</mixed-citation></ref>
<ref id="c71"><mixed-citation publication-type="journal"><string-name><surname>Ware</surname>, <given-names>C.B.</given-names></string-name> (<year>2016</year>). <article-title>Concise Review: Lessons from Na&#x00EF;ve Human Pluripotent Cells</article-title>. <source>STEM CELLS</source>.</mixed-citation></ref>
<ref id="c72"><mixed-citation publication-type="journal"><string-name><surname>Ware</surname>, <given-names>C.B.</given-names></string-name>, <string-name><surname>Nelson</surname>, <given-names>A.M.</given-names></string-name>, <string-name><surname>Mecham</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Hesson</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zhou</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Jonlin</surname>, <given-names>E.C.</given-names></string-name>, <string-name><surname>Jimenez-Caliani</surname>, <given-names>A.J.</given-names></string-name>, <string-name><surname>Deng</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Cavanaugh</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Cook</surname>, <given-names>S.</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title>Derivation of naive human embryonic stem cells</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>111</volume>, <fpage>4484</fpage>&#x2013;<lpage>4489</lpage>.</mixed-citation></ref>
<ref id="c73"><mixed-citation publication-type="journal"><string-name><surname>Whyte</surname>, <given-names>W.A.</given-names></string-name>, <string-name><surname>Bilodeau</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Orlando</surname>, <given-names>D.A.</given-names></string-name>, <string-name><surname>Hoke</surname>, <given-names>H.A.</given-names></string-name>, <string-name><surname>Frampton</surname>, <given-names>G.M.</given-names></string-name>, <string-name><surname>Foster</surname>, <given-names>C.T.</given-names></string-name>, <string-name><surname>Cowley</surname>, <given-names>S.M.</given-names></string-name>, and <string-name><surname>Young</surname>, <given-names>R.A.</given-names></string-name> (<year>2012</year>). <article-title>Enhancer decommissioning by LSD1 during embryonic stem cell differentiation</article-title>. <source>Nature</source> <volume>482</volume>, <fpage>221</fpage>&#x2013;<lpage>225</lpage>.</mixed-citation></ref>
<ref id="c74"><mixed-citation publication-type="journal"><string-name><surname>Whyte</surname>, <given-names>W.A.</given-names></string-name>, <string-name><surname>Orlando</surname>, <given-names>D.A.</given-names></string-name>, <string-name><surname>Hnisz</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Abraham</surname>, <given-names>B.J.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>C.Y.</given-names></string-name>, <string-name><surname>Kagey</surname>, <given-names>M.H.</given-names></string-name>, <string-name><surname>Rahl</surname>, <given-names>P.B.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>T.I.</given-names></string-name>, and <string-name><surname>Young</surname>, <given-names>R.A.</given-names></string-name> (<year>2013</year>). <article-title>Master transcription factors and mediator establish super-enhancers at key cell identity genes</article-title>. <source>Cell</source> <volume>153</volume>, <fpage>307</fpage>&#x2013;<lpage>319</lpage>.</mixed-citation></ref>
<ref id="c75"><mixed-citation publication-type="book"><string-name><surname>Wickham</surname>, <given-names>H.</given-names></string-name> (<year>2009</year>). <source>ggplot2: Elegant Graphics for Data Analysis</source>. In (<publisher-name>Springer-Verlag</publisher-name> <publisher-loc>New York</publisher-loc>).</mixed-citation></ref>
<ref id="c76"><mixed-citation publication-type="journal"><string-name><surname>Wiekowski</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Miranda</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Nothias</surname>, <given-names>J.Y.</given-names></string-name>, and <string-name><surname>DePamphilis</surname>, <given-names>M.L.</given-names></string-name> (<year>1997</year>). <article-title>Changes in histone synthesis and modification at the beginning of mouse development correlate with the establishment of chromatin mediated repression of transcription</article-title>. <source>J Cell Sci</source> <volume>110</volume> (<issue>Pt 10</issue>), <fpage>1147</fpage>&#x2013;<lpage>1158</lpage>.</mixed-citation></ref>
<ref id="c77"><mixed-citation publication-type="journal"><string-name><surname>Yan</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Guo</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Lian</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Zheng</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Yan</surname>, <given-names>J.</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>). <article-title>Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells</article-title>. <source>Nat Struct Mol Biol</source> <volume>20</volume>, <fpage>1131</fpage>&#x2013;<lpage>1139</lpage>.</mixed-citation></ref>
<ref id="c78"><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>, <given-names>H.M.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>C.J.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Jia</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Xue</surname>, <given-names>Y.</given-names></string-name>, and <string-name><surname>Guo</surname>, <given-names>A.Y.</given-names></string-name> (<year>2015</year>). <article-title>AnimalTFDB 2.0: a resource for expression, prediction and functional study of animal transcription factors</article-title>. <source>Nucleic Acids Res</source> <volume>43</volume>, <fpage>D76</fpage>&#x2013;<lpage>81</lpage>.</mixed-citation></ref>
<ref id="c79"><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Meyer</surname>, <given-names>C.A.</given-names></string-name>, <string-name><surname>Eeckhoute</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Johnson</surname>, <given-names>D.S.</given-names></string-name>, <string-name><surname>Bernstein</surname>, <given-names>B.E.</given-names></string-name>, <string-name><surname>Nusbaum</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Myers</surname>, <given-names>R.M.</given-names></string-name>, <string-name><surname>Brown</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>W.</given-names></string-name>, <etal>et al.</etal> (<year>2008</year>). <article-title>Model-based analysis of ChIP-Seq (MACS)</article-title>. <source>Genome Biol</source> <volume>9</volume>, <fpage>R137</fpage>.</mixed-citation></ref>
<ref id="c80"><mixed-citation publication-type="journal"><string-name><surname>Zheng</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Huang</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Xiang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Du</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Peng</surname>, <given-names>X.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title>Resetting Epigenetic Memory by Reprogramming of Histone Modifications in Mammals</article-title>. <source>Mol Cell</source> <volume>63</volume>, <fpage>1066</fpage>&#x2013;<lpage>1079</lpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>